title: hf2597_E03_Cabozantinib_0.5_24 HF2597PS1BS147_ACAAAGGA

description:
hf2597_E03_Cabozantinib_0.5_24
HF2597_dream_counts.csv

value: Cabozantinib


title: hf2597_C07_Regorafenib_0.31_24 HF2597PS1BS127_ATCAGGCT

status: Public on Oct 28 2021

type: SRA

city: Athens

first: Eugene

last: Douglass

state: GA

address: 240 West Green Street

country: USA

institute: University of Georgia

description:
hf2597_C07_Regorafenib_0.31_24
HF2597_dream_counts.csv

library_source: transcriptomic

data_processing:
Sequencing was performed in a Hi Seq 2500 sequencer (Illumina) and base calling was performed with Illumina HCS software.
RNASeq reads were mapped for each well to the human reference genome assembly 38 using the STAR aligner (Dobin et al., 2013), version 2.5.2b
Individual counts files were combined across genes and ERCC2 spike-in counts removed, yielding the raw counts file for each cell-line experiment.
Genome_build: hg38
Supplementary_files_format_and_content: 11 tab delinated text files (for 11 cell-lines) with raw gene counts for every gene and every sample

molecule: total RNA

organism: Homo sapiens

source_name: glioblastoma

extract_protocol:
Cells are lysed for PLATE-Seq in Buffer TCL (Qiagen) supplemented with 2-mercaptoethanol in 96-well plates. We transfer 30 μl of cell lysate from each well to a 96-well plate with oligo(dT) grafted to the wells (mRNA TurboCapture Plate, Qiagen) and added 1 μl of 1:100 dilution of ERCC Ex-Fold Spike-Ins (ThermoFisher) to a subset of the sample wells. The plate is then centrifuged at 295 × g for 1 min to eliminate air bubbles followed by incubation for 90 min at room temperature with shaking at 200 rpm. Lysate is then removed from the oligo(dT) capture plate and wells are washed three times with Buffer TCW (Qiagen) using the 96 CO-RE Head of a Hamilton Microlab STAR automated liquid handling system. After drying the plate, mRNA is then eluted by adding 30 μl of elution buffer (nuclease-free water supplemented with 0.4 U μl−1 SUPERaseIN (ThermoFisher)), incubation at 65 °C for 5 min, and incubation at room temperature for 5 min. mRNA samples are then transferred to a new PCR plate (Hard-Shell PCR plate, 96-well, Bio-Rad) using sterile-filter 96-well, 50 μl tips on the Hamilton STAR. To anneal primers for reverse transcription, 3 μl of 100 μM adapter-linked oligo(dT) primers are added to each well along with 10 μl of 5× ProtoScript RT Buffer (New England BioLabs) with the Hamilton STAR CO-RE Head and 1000 μl channel pipetting system (see Supplementary Table 2 for “PLATEseq_oligodTBC” sequences). The plate is then heated to 94 °C for 2 min and placed immediately on ice for 5 min. The remaining components of the reverse transcription master mix including 0.5 mM of each dNTP, 10 mM DTT, 35.8 U of Protoscript II Reverse Transcriptase (New England BioLabs), and water are then added to bring the final reaction volume to 50 μl per well. The plate is then centrifuged at 295 × g for 1 min and incubated at 42 °C for 2 h. At this point, the samples can optionally be frozen at −80 °C. To remove excess primer, 1 μl of a fourfold dilution of Exonuclease I (New England BioLabs) is added to each sample. The Exonculease I reaction is incubated at 25 °C for 1 h. To hydrolyze the RNA, we add 20 μl of a 1:1 mixture of 1 M sodium hydroxide and 0.5 M EDTA to each well and incubate at 65 °C for 15 min. The wells are then pooled together into a single tube to which 80 μl of 12 M hydrochloric acid are added to neutralize the sample. At this point, the pooled sample can optionally be frozen at −80 °C. The pooled, neutralized sample is purified and concentrated using a Qiagen MinElute column using a vacuum apparatus according to the manufacturer’s instructions, and pooled cDNA is eluted in 15 μl of nuclease-free water. For second-strand synthesis, 1 μl of 10 mM dNTP mixture and 1 μl of 100 mM adapter-linked random hexamer primers are added to the pooled cDNA sample. The mixture is then heated to 70 °C for 2 min and immediately placed on ice for 5 min. Next, 2 μl of NEB Buffer 2 (New England BioLabs) and 1 μl of Klenow large fragment DNA polymerase (New England BioLabs) are added and the reaction is incubated at room temperature for 30 min. The reaction is then stopped by addition of EDTA to a final concentration of 50 μM the double-stranded cDNA is purified with two rounds of bead clean-up using AMPure XP beads (Beckman Counter) at a 1:1 bead-to-sample ratio. Finally, the double-stranded cDNA pool is amplified by PCR using Phusion DNA Polymerase (New England BioLabs)
RNA libraries were prepared for sequencing using standard Illumina protocols

treatment_protocol: Cell-lines were treated at a 48-hour IC20 for each drug and RNA was collected at 24 hours to minimize cell-death.

tag: treatment

value: Regorafenib

tag: cell line

tag: provider

value: Henry Ford Fnd

tag: vendor id

tag: age

tag: Sex


title: hf2597_H07_Gefitinib_0.5_24 HF2597PS1BS187_ATCAACAC

description:
hf2597_H07_Gefitinib_0.5_24
HF2597_dream_counts.csv

value: Gefitinib


title: hf2597_F06_UNTREATED__24 HF2597PS1BS162_CTCTTACG

description:
hf2597_F06_UNTREATED__24
HF2597_dream_counts.csv

value: UNTREATED


title: hf2597_B05_Dasatinib_0.345_24 HF2597PS1BS113_CTTGAAAG

description:
hf2597_B05_Dasatinib_0.345_24
HF2597_dream_counts.csv

value: Dasatinib


title: hf2597_B02_DMSO__24 HF2597PS1BS110_CTGAGGTC

description:
hf2597_B02_DMSO__24
HF2597_dream_counts.csv

value: DMSO


title: hf2597_F11_DMSO__24 HF2597PS1BS167_GCTAAGAC

description:
hf2597_F11_DMSO__24
HF2597_dream_counts.csv


title: hf2597_H11_UNTREATED__24 HF2597PS1AS95_CGGTGATA

description:
hf2597_H11_UNTREATED__24
HF2597_dream_counts.csv


title: hf2597_D07_AZD5363_0.26_24 HF2597PS2AS235_AAGCGCAC

description:
hf2597_D07_AZD5363_0.26_24
HF2597_dream_counts.csv


title: hf2597_H07_Gefitinib_0.5_24 HF2597PS1AS91_AAGAGAGG


title: hf2597_D07_Bosutinib_0.375_24 HF2597PS1BS139_GTCAGAAC

description:
hf2597_D07_Bosutinib_0.375_24
HF2597_dream_counts.csv

value: Bosutinib


title: hf2597_D02_UNTREATED__24 HF2597PS1BS134_TATGCGTG

description:
hf2597_D02_UNTREATED__24
HF2597_dream_counts.csv


title: hf2597_C06_DMSO__24 HF2597PS2AS222_AACCATCC

description:
hf2597_C06_DMSO__24
HF2597_dream_counts.csv


title: hf2597_D05_Afatinib_0.185_24 HF2597PS1BS137_GACAAAGA

description:
hf2597_D05_Afatinib_0.185_24
HF2597_dream_counts.csv

value: Afatinib


title: hf2597_F11_DMSO__24 HF2597PS1AS71_ATTGTGGC


title: hf2597_C06_DMSO__24 HF2597PS1BS126_CTGGTCAT


title: hf2597_E11_DMSO__24 HF2597PS1AS59_CTAGCATC

description:
hf2597_E11_DMSO__24
HF2597_dream_counts.csv


title: hf2597_C02_UNTREATED__24 HF2597PS1BS122_TGTCAACG

description:
hf2597_C02_UNTREATED__24
HF2597_dream_counts.csv


title: hf2597_E03_Cabozantinib_0.5_24 HF2597PS1AS51_TTACCGTG


title: hf2597_D09_Ponatinib_0.04_24 HF2597PS1AS45_CGCAAAAT

description:
hf2597_D09_Ponatinib_0.04_24
HF2597_dream_counts.csv

value: Ponatinib


title: hf2597_D07_Bosutinib_0.375_24 HF2597PS1AS43_GTCAAGGT


title: hf2597_C07_Regorafenib_0.31_24 HF2597PS1AS31_TAGCTAGC


title: hf2597_D06_DMSO__24 HF2597PS1AS42_ACACGCCA

description:
hf2597_D06_DMSO__24
HF2597_dream_counts.csv


title: hf2597_G03_Osimertinib_1.5_24 HF2597PS1AS75_TACGAGCA

description:
hf2597_G03_Osimertinib_1.5_24
HF2597_dream_counts.csv

value: Osimertinib


title: hf2597_A02_DMSO__24 HF2597PS1BS98_ACATGTTG

description:
hf2597_A02_DMSO__24
HF2597_dream_counts.csv


title: hf2597_C06_DMSO__24 HF2597PS1AS30_AACAGTTG


title: hf2597_E06_UNTREATED__24 HF2597PS1AS54_TTTCTCCC

description:
hf2597_E06_UNTREATED__24
HF2597_dream_counts.csv


title: hf2597_F06_UNTREATED__24 HF2597PS1AS66_TCATTGGA

description:
hf2597_F06_UNTREATED__24
HF2597_dream_counts.csv


title: hf2597_A02_DMSO__24 HF2597PS1AS2_CGTTGTCA


title: hf2597_C02_UNTREATED__24 HF2597PS1AS26_TTTTACCG


title: hcc1143_H11_UNTREATED__24 HCCPS5BS671_TAACCCGA

description:
hcc1143_H11_UNTREATED__24
HCC1143_dream_counts.csv

source_name: breast cancer

value: ATCC

value: female


title: hf2597_G11_UNTREATED__24 HF2597PS1AS83_GTCGCACA

description:
hf2597_G11_UNTREATED__24
HF2597_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCCPS5BS659_ATACGCAT

description:
hcc1143_G11_UNTREATED__24
HCC1143_dream_counts.csv


title: hf2597_B02_DMSO__24 HF2597PS1AS14_CAGTACCT

description:
hf2597_B02_DMSO__24
HF2597_dream_counts.csv


title: hcc1143_F11_DMSO__24 HCCPS5BS647_CTGCCAAC

description:
hcc1143_F11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_F6_UNTREATED__24 HCCPS5BS642_AGATAGGT

description:
hcc1143_F6_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO__24 HCCPS5BS635_GAGAGAAA

description:
hcc1143_E11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_D2_UNTREATED__24 HCCPS5BS614_GGCGTTCA

description:
hcc1143_D2_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E6_UNTREATED__24 HCCPS5BS630_AACTTGGC

description:
hcc1143_E6_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_D6_DMSO_0_24 HCCPS5BS618_GTTGTTGT

description:
hcc1143_D6_DMSO_0_24
HCC1143_dream_counts.csv


title: hf2597_F01_Lapatinib_2_24 HF2597PS1AS61_TGCAGCTG

description:
hf2597_F01_Lapatinib_2_24
HF2597_dream_counts.csv

value: Lapatinib


title: hcc1143_C2_UNTREATED__24 HCCPS5BS602_GAGGTCTT

description:
hcc1143_C2_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C6_DMSO__24 HCCPS5BS606_TATGGCCA

description:
hcc1143_C6_DMSO__24
HCC1143_dream_counts.csv


title: hf2597_D02_UNTREATED__24 HF2597PS1AS38_ATCATGTG

description:
hf2597_D02_UNTREATED__24
HF2597_dream_counts.csv


title: hcc1143_B2_DMSO__24 HCCPS5BS590_CGTGTAGG

description:
hcc1143_B2_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCCPS5AS563_ATAGGGCG


title: hcc1143_A2_DMSO__24 HCCPS5BS578_AGACGTTT

description:
hcc1143_A2_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_D6_DMSO_0_24 HCCPS5AS522_GAAGTCCA


title: hcc1143_F11_DMSO__24 HCCPS5AS551_TAGGTTTC


title: hf2597_D05_Afatinib_0.185_24 HF2597PS1AS41_ACGACCTC

description:
hf2597_D05_Afatinib_0.185_24
HF2597_dream_counts.csv


title: hcc1143_F6_UNTREATED__24 HCCPS5AS546_CGAAGAGT


title: hf2597_B05_Dasatinib_0.345_24 HF2597PS1AS17_TCTCAGAA

description:
hf2597_B05_Dasatinib_0.345_24
HF2597_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCCPS5AS575_AGAGTGTC

description:
hcc1143_H11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO__24 HCCPS5AS539_GACAGTCT


title: hcc1143_C6_DMSO__24 HCCPS5AS510_ACCGCTAG


title: hcc1143_E6_UNTREATED__24 HCCPS5AS534_ACTATCTG


title: hcc1143_B2_DMSO__24 HCCPS5AS494_GACTGAGG


title: hcc1143_C2_UNTREATED__24 HCCPS5AS506_CCCCTTCA


title: hcc1143_H11_UNTREATED__24 HCC1143PS4BS95_CGGTGATA


title: hcc1143_H03_Bafetinib_5.5_24 HCC1143PS4BS87_GCGCCTTA

description:
hcc1143_H03_Bafetinib_5.5_24
HCC1143_dream_counts.csv

value: Bafetinib


title: hcc1143_A2_DMSO__24 HCCPS5AS482_CGAAGCCA


title: hcc1143_H05_MK2206_0.165_24 HCC1143PS4BS89_CTTAGGCA

description:
hcc1143_H05_MK2206_0.165_24
HCC1143_dream_counts.csv


title: hcc1143_G07_Neratinib_0.225_24 HCC1143PS4BS79_GTGTGCTA

description:
hcc1143_G07_Neratinib_0.225_24
HCC1143_dream_counts.csv

value: Neratinib


title: hcc1143_F06_UNTREATED__24 HCC1143PS4BS66_TCATTGGA

description:
hcc1143_F06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO__24 HCC1143PS4BS71_ATTGTGGC

description:
hcc1143_F11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO__24 HCC1143PS4BS59_CTAGCATC

description:
hcc1143_E11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_E06_UNTREATED__24 HCC1143PS4BS54_TTTCTCCC

description:
hcc1143_E06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_D02_UNTREATED__24 HCC1143PS4BS38_ATCATGTG

description:
hcc1143_D02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E05_Tivantinib_0.11_24 HCC1143PS4BS53_GGTGATCT

description:
hcc1143_E05_Tivantinib_0.11_24
HCC1143_dream_counts.csv

value: Tivantinib


title: hcc1143_D06_DMSO__24 HCC1143PS4BS42_ACACGCCA

description:
hcc1143_D06_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_C06_DMSO__24 HCC1143PS4BS30_AACAGTTG

description:
hcc1143_C06_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_C02_UNTREATED__24 HCC1143PS4BS26_TTTTACCG

description:
hcc1143_C02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C05_Linifanib_0.5_24 HCC1143PS4BS29_TTCCCGCA

description:
hcc1143_C05_Linifanib_0.5_24
HCC1143_dream_counts.csv

value: Linifanib


title: hcc1143_A07_Foretinib_0.055_24 HCC1143PS4BS7_CCTCAAGC

description:
hcc1143_A07_Foretinib_0.055_24
HCC1143_dream_counts.csv

value: Foretinib


title: hcc1143_D2_UNTREATED__24 HCCPS5AS518_GACGACTC

description:
hcc1143_D2_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_B02_DMSO__24 HCC1143PS4BS14_CAGTACCT

description:
hcc1143_B02_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_A02_DMSO__24 HCC1143PS4BS2_CGTTGTCA

description:
hcc1143_A02_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_A05_KW2449_1.5_24 HCC1143PS4BS5_CTTAGTTG

description:
hcc1143_A05_KW2449_1.5_24
HCC1143_dream_counts.csv


title: hcc1143_A03_AZD5363_0.18_24 HCC1143PS4BS3_TGAATCAG

description:
hcc1143_A03_AZD5363_0.18_24
HCC1143_dream_counts.csv


title: hcc1143_H05_MK2206_0.165_24 HCC1143PS4AS761_GCATCCTG

description:
hcc1143_H05_MK2206_0.165_24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS4BS83_GTCGCACA

description:
hcc1143_G11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCC1143PS4AS767_ACAAGTCT

description:
hcc1143_H11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_G07_Neratinib_0.225_24 HCC1143PS4AS751_CTTGAGCT

description:
hcc1143_G07_Neratinib_0.225_24
HCC1143_dream_counts.csv


title: hcc1143_H03_Bafetinib_5.5_24 HCC1143PS4AS759_TTGGGTTT

description:
hcc1143_H03_Bafetinib_5.5_24
HCC1143_dream_counts.csv


title: hcc1143_F06_UNTREATED__24 HCC1143PS4AS738_GCTTACCA

description:
hcc1143_F06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO__24 HCC1143PS4AS743_GTGATGAC

description:
hcc1143_F11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS4AS755_GGGCTTCT


title: hcc1143_E11_DMSO__24 HCC1143PS4AS731_CACCCTAC

description:
hcc1143_E11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_E06_UNTREATED__24 HCC1143PS4AS726_ATTCACAG

description:
hcc1143_E06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_D02_UNTREATED__24 HCC1143PS4AS710_GCTGCGTA

description:
hcc1143_D02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E05_Tivantinib_0.11_24 HCC1143PS4AS725_GACGTACC

description:
hcc1143_E05_Tivantinib_0.11_24
HCC1143_dream_counts.csv


title: hcc1143_C02_UNTREATED__24 HCC1143PS4AS698_AGCAGCGT

description:
hcc1143_C02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C06_DMSO__24 HCC1143PS4AS702_TCCAGCAA

description:
hcc1143_C06_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_A05_KW2449_1.5_24 HCC1143PS4AS677_GAATGGGC


title: hcc1143_A03_AZD5363_0.18_24 HCC1143PS4AS675_ACTGGGAT


title: hcc1143_A07_Foretinib_0.055_24 HCC1143PS4AS679_CTGAATAC

description:
hcc1143_A07_Foretinib_0.055_24
HCC1143_dream_counts.csv


title: hcc1143_C05_Linifanib_0.5_24 HCC1143PS4AS701_TGTAGCCC

description:
hcc1143_C05_Linifanib_0.5_24
HCC1143_dream_counts.csv


title: hcc1143_A02_DMSO__24 HCC1143PS4AS674_GGAGGGAA

description:
hcc1143_A02_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCC1143PS3BS671_TAACCCGA


title: hcc1143_G11_UNTREATED__24 HCC1143PS3BS659_ATACGCAT


title: hcc1143_F11_DMSO__24 HCC1143PS3BS647_CTGCCAAC


title: hcc1143_F06_UNTREATED__24 HCC1143PS3BS642_AGATAGGT


title: hcc1143_E11_DMSO__24 HCC1143PS3BS635_GAGAGAAA


title: hcc1143_E06_UNTREATED__24 HCC1143PS3BS630_AACTTGGC


title: hcc1143_D02_UNTREATED__24 HCC1143PS3BS614_GGCGTTCA


title: hcc1143_C06_DMSO__24 HCC1143PS3BS606_TATGGCCA


title: hcc1143_C02_UNTREATED__24 HCC1143PS3BS602_GAGGTCTT


title: hcc1143_D06_DMSO__24 HCC1143PS3BS618_GTTGTTGT

description:
hcc1143_D06_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS3AS563_ATAGGGCG


title: hcc1143_E11_DMSO__24 HCC1143PS3AS539_GACAGTCT


title: hcc1143_B02_DMSO__24 HCC1143PS3BS590_CGTGTAGG

description:
hcc1143_B02_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_A02_DMSO__24 HCC1143PS3BS578_AGACGTTT


title: hcc1143_D06_DMSO__24 HCC1143PS4AS714_CTGTGAGT


title: hcc1143_E06_UNTREATED__24 HCC1143PS3AS534_ACTATCTG


title: hcc1143_C02_UNTREATED__24 HCC1143PS3AS506_CCCCTTCA


title: hcc1143_C06_DMSO__24 HCC1143PS3AS510_ACCGCTAG


title: hcc1143_F06_UNTREATED__24 HCC1143PS3AS546_CGAAGAGT


title: hcc1143_H06_Crenolanib_0.145_24 HCC1143PS2BS474_AGAAGATG

description:
hcc1143_H06_Crenolanib_0.145_24
HCC1143_dream_counts.csv

value: Crenolanib


title: hcc1143_D02_UNTREATED__24 HCC1143PS3AS518_GACGACTC


title: hcc1143_G12_Sunitinib_0.045_24 HCC1143PS2BS468_GTATTAGC

description:
hcc1143_G12_Sunitinib_0.045_24
HCC1143_dream_counts.csv

value: Sunitinib


title: hcc1143_B02_DMSO__24 HCC1143PS3AS494_GACTGAGG


title: hcc1143_B02_DMSO__24 HCC1143PS4AS686_CTAATCCC


title: hcc1143_D06_DMSO__24 HCC1143PS3AS522_GAAGTCCA


title: hcc1143_G11_UNTREATED__24 HCC1143PS2BS467_TCACAAGA

description:
hcc1143_G11_UNTREATED__24
HCC1143_dream_counts.csv

value: UNTREATED


title: hcc1143_A02_DMSO__24 HCC1143PS3AS482_CGAAGCCA


title: hcc1143_G01_Regorafenib_5_24 HCC1143PS2BS457_CTCTCAAT

description:
hcc1143_G01_Regorafenib_5_24
HCC1143_dream_counts.csv

value: Regorafenib


title: hcc1143_G07_MGCD265_1_24 HCC1143PS2BS463_TTTCCTAG

description:
hcc1143_G07_MGCD265_1_24
HCC1143_dream_counts.csv


title: hcc1143_F06_UNTREATED__24 HCC1143PS2BS450_GTGATAGT

description:
hcc1143_F06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_H01_Ponatinib_0.135_24 HCC1143PS2BS469_TCTGAACT

description:
hcc1143_H01_Ponatinib_0.135_24
HCC1143_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCC1143PS3AS575_AGAGTGTC

description:
hcc1143_H11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_H12_Sorafenib_4.5_24 HCC1143PS2BS480_TGTTCCTG

description:
hcc1143_H12_Sorafenib_4.5_24
HCC1143_dream_counts.csv

value: Sorafenib


title: hcc1143_D06_DMSO_0_24 HCC1143PS2BS426_TCGTCGCT

description:
hcc1143_D06_DMSO_0_24
HCC1143_dream_counts.csv

value: DMSO


title: hcc1143_D03_AEE788_0.17_24 HCC1143PS2BS423_GAAGTTAG

description:
hcc1143_D03_AEE788_0.17_24
HCC1143_dream_counts.csv


title: hcc1143_D02_UNTREATED__24 HCC1143PS2BS422_ACGTGGCA

description:
hcc1143_D02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO_0_24 HCC1143PS2BS455_CACTTGAT

description:
hcc1143_F11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E06_UNTREATED__24 HCC1143PS2BS438_CTGACGGT

description:
hcc1143_E06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO__24 HCC1143PS3AS551_TAGGTTTC

description:
hcc1143_F11_DMSO__24
HCC1143_dream_counts.csv


title: hcc1143_E04_Dacomitinib_0.04_24 HCC1143PS2BS436_TATTCTCC

description:
hcc1143_E04_Dacomitinib_0.04_24
HCC1143_dream_counts.csv

value: Dacomitinib


title: hcc1143_C05_Varlitinib_0.09_24 HCC1143PS2BS413_TCTTGGTA

description:
hcc1143_C05_Varlitinib_0.09_24
HCC1143_dream_counts.csv

value: Varlitinib


title: hcc1143_E11_DMSO_0_24 HCC1143PS2BS443_AATGGCGT

description:
hcc1143_E11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCC1143PS2BS479_GCGACGAA


title: hcc1143_C03_Icotinib_7.5_24 HCC1143PS2BS411_TTGGTGGG

description:
hcc1143_C03_Icotinib_7.5_24
HCC1143_dream_counts.csv

value: Icotinib


title: hcc1143_H11_UNTREATED__24 HCC1143PS2AS383_AAGTGGAT

value: ATCC


title: hcc1143_E07_Dovitinib_0.5_24 HCC1143PS2BS439_ATGTCGAC

description:
hcc1143_E07_Dovitinib_0.5_24
HCC1143_dream_counts.csv

value: Dovitinib

value: female


title: hcc1143_B08_Quizartinib_0.3_24 HCC1143PS2BS404_GGCTCATT

description:
hcc1143_B08_Quizartinib_0.3_24
HCC1143_dream_counts.csv

value: Quizartinib


title: hcc1143_H12_Sorafenib_4.5_24 HCC1143PS2AS384_AGGGAATT


title: hcc1143_A02_DMSO_0_24 HCC1143PS2BS386_GTAACGCT

description:
hcc1143_A02_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_A08_Vandetanib_0.03_24 HCC1143PS2BS392_GTGACGTG

description:
hcc1143_A08_Vandetanib_0.03_24
HCC1143_dream_counts.csv

value: Vandetanib


title: hcc1143_H1_Ponatinib_0.135_24 HCC1143PS2AS373_ATACGGGC

description:
hcc1143_H1_Ponatinib_0.135_24
HCC1143_dream_counts.csv

value: Ponatinib


title: hcc1143_F11_DMSO_0_24 HCC1143PS2AS359_ATGCCATT


title: hcc1143_G1_Regorafenib_5_24 HCC1143PS2AS361_CCGCAAAT

description:
hcc1143_G1_Regorafenib_5_24
HCC1143_dream_counts.csv


title: hcc1143_G7_MGCD265_1_24 HCC1143PS2AS367_TACCCTTG

description:
hcc1143_G7_MGCD265_1_24
HCC1143_dream_counts.csv


title: hcc1143_B02_DMSO_0_24 HCC1143PS2BS398_GGGAGATT

description:
hcc1143_B02_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_G12_Sunitinib_0.045_24 HCC1143PS2AS372_GCTTTTAC

description:
hcc1143_G12_Sunitinib_0.045_24
HCC1143_dream_counts.csv


title: hcc1143_F6_UNTREATED__24 HCC1143PS2AS354_TAGGAGAT

description:
hcc1143_F6_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO_0_24 HCC1143PS2AS347_GAACAGAC


title: hcc1143_H6_Crenolanib_0.145_24 HCC1143PS2AS378_CGCTCTAA

description:
hcc1143_H6_Crenolanib_0.145_24
HCC1143_dream_counts.csv


title: hcc1143_B05_Cediranib_0.22_24 HCC1143PS2BS401_CTCGGGAT

description:
hcc1143_B05_Cediranib_0.22_24
HCC1143_dream_counts.csv

value: Cediranib


title: hcc1143_E6_UNTREATED__24 HCC1143PS2AS342_GGAACTCA

description:
hcc1143_E6_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C06_DMSO_0_24 HCC1143PS2BS414_TGGTGGTG

description:
hcc1143_C06_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E4_Dacomitinib_0.04_24 HCC1143PS2AS340_ACCTTACA

description:
hcc1143_E4_Dacomitinib_0.04_24
HCC1143_dream_counts.csv


title: hcc1143_D6_DMSO_0_24 HCC1143PS2AS330_GAGTGTAG

description:
hcc1143_D6_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_C02_UNTREATED__24 HCC1143PS2BS410_CCGGCTAT

description:
hcc1143_C02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E7_Dovitinib_0.5_24 HCC1143PS2AS343_ACGAAAGC

description:
hcc1143_E7_Dovitinib_0.5_24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS2AS371_GTGCGAAG

description:
hcc1143_G11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C5_Varlitinib_0.09_24 HCC1143PS2AS317_CCTACGTG

description:
hcc1143_C5_Varlitinib_0.09_24
HCC1143_dream_counts.csv


title: hcc1143_D3_AEE788_0.17_24 HCC1143PS2AS327_TCTGTCCG

description:
hcc1143_D3_AEE788_0.17_24
HCC1143_dream_counts.csv


title: hcc1143_D2_UNTREATED__24 HCC1143PS2AS326_CATGAAGA

description:
hcc1143_D2_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C3_Icotinib_7.5_24 HCC1143PS2AS315_GCTATCAT

description:
hcc1143_C3_Icotinib_7.5_24
HCC1143_dream_counts.csv


title: hcc1143_C6_DMSO_0_24 HCC1143PS2AS318_AACGGTAC

description:
hcc1143_C6_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_C2_UNTREATED__24 HCC1143PS2AS314_TAAGTCGC

description:
hcc1143_C2_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_B5_Cediranib_0.22_24 HCC1143PS2AS305_CCATAGAG

description:
hcc1143_B5_Cediranib_0.22_24
HCC1143_dream_counts.csv


title: hcc1143_B2_DMSO_0_24 HCC1143PS2AS302_CATTTGCA

description:
hcc1143_B2_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_A8_Vandetanib_0.03_24 HCC1143PS2AS296_CCGAGAGA

description:
hcc1143_A8_Vandetanib_0.03_24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS1BS275_GCCTCGAT


title: hcc1143_B8_Quizartinib_0.3_24 HCC1143PS2AS308_TCTCGTCC

description:
hcc1143_B8_Quizartinib_0.3_24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO_0_24 HCC1143PS1BS263_ATCGATTC

description:
hcc1143_F11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_G02_Gefitinib_0.5_24 HCC1143PS1BS266_CCTGTGGT

description:
hcc1143_G02_Gefitinib_0.5_24
HCC1143_dream_counts.csv

value: Gefitinib


title: hcc1143_G10_Dasatinib_0.345_24 HCC1143PS1BS274_CTGGTTTG

description:
hcc1143_G10_Dasatinib_0.345_24
HCC1143_dream_counts.csv

value: Dasatinib


title: hcc1143_H10_Afatinib_0.125_24 HCC1143PS1BS286_GACAACAT

description:
hcc1143_H10_Afatinib_0.125_24
HCC1143_dream_counts.csv

value: Afatinib


title: hcc1143_A2_DMSO_0_24 HCC1143PS2AS290_CTATACCA

description:
hcc1143_A2_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO_0_24 HCC1143PS1BS251_GGAAAAGC

description:
hcc1143_E11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E07_Imatinib_2.5_24 HCC1143PS1BS247_CCCACCAT

description:
hcc1143_E07_Imatinib_2.5_24
HCC1143_dream_counts.csv

value: Imatinib


title: hcc1143_H11_UNTREATED__24 HCC1143PS1BS287_GCACTAAT

description:
hcc1143_H11_UNTREATED__24
HCC1143_dream_counts.csv

value: UNTREATED


title: hcc1143_F06_UNTREATED__24 HCC1143PS1BS258_TCCCTGAC

description:
hcc1143_F06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E03_Lapatinib_1_24 HCC1143PS1BS243_TCGCAATG

description:
hcc1143_E03_Lapatinib_1_24
HCC1143_dream_counts.csv

value: Lapatinib


title: hcc1143_E02_Bosutinib_0.5_24 HCC1143PS1BS242_ATATTCGG

description:
hcc1143_E02_Bosutinib_0.5_24
HCC1143_dream_counts.csv

value: Bosutinib


title: hcc1143_D06_DMSO_0_24 HCC1143PS1BS234_TGCGTCTT

description:
hcc1143_D06_DMSO_0_24
HCC1143_dream_counts.csv

value: DMSO


title: hcc1143_D09_Cabozantinib_1_24 HCC1143PS1BS237_ACTCACGA

description:
hcc1143_D09_Cabozantinib_1_24
HCC1143_dream_counts.csv

value: Cabozantinib


title: hcc1143_D02_UNTREATED__24 HCC1143PS1BS230_TGACATGC

description:
hcc1143_D02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F09_Osimertinib_1_24 HCC1143PS1BS261_AAGATGCT

description:
hcc1143_F09_Osimertinib_1_24
HCC1143_dream_counts.csv

value: Osimertinib


title: hcc1143_C07_Nilotinib_0.27_24 HCC1143PS1BS223_GTATTCCT

description:
hcc1143_C07_Nilotinib_0.27_24
HCC1143_dream_counts.csv

value: Nilotinib

value: ATCC


title: hcc1143_C06_DMSO_0_24 HCC1143PS1BS222_AACCATCC

description:
hcc1143_C06_DMSO_0_24
HCC1143_dream_counts.csv

value: female


title: hcc1143_B02_DMSO_0_24 HCC1143PS1BS206_GTCCGTTG

description:
hcc1143_B02_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_C02_UNTREATED__24 HCC1143PS1BS218_AATTCGTC

description:
hcc1143_C02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_B06_Crizotinib_0.19_24 HCC1143PS1BS210_CTGGGAAA

description:
hcc1143_B06_Crizotinib_0.19_24
HCC1143_dream_counts.csv

value: Crizotinib


title: hcc1143_H10_Afatinib_0.125_24 HCC1143PS1AS190_TTCGCTTA

description:
hcc1143_H10_Afatinib_0.125_24
HCC1143_dream_counts.csv


title: hcc1143_A02_DMSO_0_24 HCC1143PS1BS194_GAGCTGGT

description:
hcc1143_A02_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_G11_UNTREATED__24 HCC1143PS1AS179_TTCAGAGT

description:
hcc1143_G11_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_H11_UNTREATED__24 HCC1143PS1AS191_TGTCGTGA


title: hcc1143_G2_Gefitinib_0.5_24 HCC1143PS1AS170_CGGATTTC

description:
hcc1143_G2_Gefitinib_0.5_24
HCC1143_dream_counts.csv


title: hcc1143_G10_Dasatinib_0.345_24 HCC1143PS1AS178_ATGTAGTG

description:
hcc1143_G10_Dasatinib_0.345_24
HCC1143_dream_counts.csv


title: hcc1143_E11_DMSO_0_24 HCC1143PS1AS155_TATACGCT

description:
hcc1143_E11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E06_UNTREATED__24 HCC1143PS1BS246_CACCTCTC

description:
hcc1143_E06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_F9_Osimertinib_1_24 HCC1143PS1AS165_CCAAAATC

description:
hcc1143_F9_Osimertinib_1_24
HCC1143_dream_counts.csv


title: hcc1143_D9_Cabozantinib_1_24 HCC1143PS1AS141_ACAATGAC

description:
hcc1143_D9_Cabozantinib_1_24
HCC1143_dream_counts.csv


title: hcc1143_D6_DMSO_0_24 HCC1143PS1AS138_AGACAGTG

description:
hcc1143_D6_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_F11_DMSO_0_24 HCC1143PS1AS167_GCTAAGAC

description:
hcc1143_F11_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_F06_UNTREATED__24 HCC1143PS1AS162_CTCTTACG

description:
hcc1143_F06_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_C7_Nilotinib_0.27_24 HCC1143PS1AS127_ATCAGGCT

description:
hcc1143_C7_Nilotinib_0.27_24
HCC1143_dream_counts.csv


title: hcc1143_E7_Imatinib_2.5_24 HCC1143PS1AS151_AGAAGTGA

description:
hcc1143_E7_Imatinib_2.5_24
HCC1143_dream_counts.csv


title: hcc1143_C6_DMSO_0_24 HCC1143PS1AS126_CTGGTCAT

description:
hcc1143_C6_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_E06_UNTREATED__24 HCC1143PS1AS150_CACTCCTG


title: hcc1143_D02_UNTREATED__24 HCC1143PS1AS134_TATGCGTG

description:
hcc1143_D02_UNTREATED__24
HCC1143_dream_counts.csv


title: hcc1143_E3_Lapatinib_1_24 HCC1143PS1AS147_ACAAAGGA

description:
hcc1143_E3_Lapatinib_1_24
HCC1143_dream_counts.csv


title: hcc1143_E2_Bosutinib_0.5_24 HCC1143PS1AS146_AAACCAGG

description:
hcc1143_E2_Bosutinib_0.5_24
HCC1143_dream_counts.csv


title: h1793_G11_UNTREATED_0_24 1793PS5BG11_GTCGCACA

description:
h1793_G11_UNTREATED_0_24
H1793_dream_counts.csv

source_name: lung cancer


title: hcc1143_A2_DMSO_0_24 HCC1143PS1AS98_ACATGTTG

description:
hcc1143_A2_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_B2_DMSO_0_24 HCC1143PS1AS110_CTGAGGTC

description:
hcc1143_B2_DMSO_0_24
HCC1143_dream_counts.csv


title: hcc1143_B6_Crizotinib_0.19_24 HCC1143PS1AS114_TACACCCC

description:
hcc1143_B6_Crizotinib_0.19_24
HCC1143_dream_counts.csv


title: h1793_F11_DMSO_0_24 1793PS5BF11_ATTGTGGC

description:
h1793_F11_DMSO_0_24
H1793_dream_counts.csv


title: h1793_E11_DMSO_0_24 1793PS5BE11_CTAGCATC

description:
h1793_E11_DMSO_0_24
H1793_dream_counts.csv


title: h1793_E6_UNTREATED_0_24 1793PS5BE06_TTTCTCCC

description:
h1793_E6_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_H11_UNTREATED_0_24 1793PS5BH11_CGGTGATA

description:
h1793_H11_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_D6_DMSO_0_24 1793PS5BD06_ACACGCCA

description:
h1793_D6_DMSO_0_24
H1793_dream_counts.csv


title: h1793_F6_UNTREATED_0_24 1793PS5BF06_TCATTGGA

description:
h1793_F6_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_C6_DMSO_0_24 1793PS5BC06_AACAGTTG

description:
h1793_C6_DMSO_0_24
H1793_dream_counts.csv


title: h1793_C2_UNTREATED_0_24 1793PS5BC02_TTTTACCG

description:
h1793_C2_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_D2_UNTREATED_0_24 1793PS5BD02_ATCATGTG

description:
h1793_D2_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_H11_UNTREATED_0_24 1793PS5AH11_CGGTGATA


title: h1793_F11_DMSO_0_24 1793PS5AF11_ATTGTGGC


title: hcc1143_C02_UNTREATED__24 HCC1143PS1AS122_TGTCAACG

description:
hcc1143_C02_UNTREATED__24
HCC1143_dream_counts.csv


title: h1793_G11_UNTREATED_0_24 1793PS5AG11_GTCGCACA


title: h1793_A2_DMSO_0_24 1793PS5BA02_CGTTGTCA

description:
h1793_A2_DMSO_0_24
H1793_dream_counts.csv


title: h1793_F6_UNTREATED_0_24 1793PS5AF06_TCATTGGA


title: h1793_E11_DMSO_0_24 1793PS5AE11_CTAGCATC


title: h1793_E6_UNTREATED_0_24 1793PS5AE06_TTTCTCCC


title: h1793_B2_DMSO_0_24 1793PS5BB02_CAGTACCT

description:
h1793_B2_DMSO_0_24
H1793_dream_counts.csv


title: h1793_C6_DMSO_0_24 1793PS5AC06_AACAGTTG


title: h1793_C2_UNTREATED_0_24 1793PS5AC02_TTTTACCG


title: h1793_B2_DMSO_0_24 1793PS5AB02_CAGTACCT


title: h1793_D6_DMSO_0_24 1793PS5AD06_ACACGCCA


title: h1793_A2_DMSO_0_24 1793PS5AA02_CGTTGTCA


title: h1793_E6_UNTREATED_0_24 1793PS4BE06_TTTCTCCC


title: h1793_D5_DMSO_0_24 1793PS4BD05_ACGACCTC

description:
h1793_D5_DMSO_0_24
H1793_dream_counts.csv


title: h1793_A7_Varlitinib_5.775_24 1793PS4BA07_CCTCAAGC

description:
h1793_A7_Varlitinib_5.775_24
H1793_dream_counts.csv

value: Varlitinib


title: h1793_A3_Quizartinib_0.577_24 1793PS4BA03_TGAATCAG

description:
h1793_A3_Quizartinib_0.577_24
H1793_dream_counts.csv

value: Quizartinib


title: h1793_D6_DMSO_0_24 1793PS4BD06_ACACGCCA


title: h1793_E6_UNTREATED_0_24 1793PS4AE06_TTTCTCCC


title: h1793_A7_Varlitinib_5.775_24 1793PS4AA07_CCTCAAGC


title: h1793_E5_UNTREATED_0_24 1793PS4BE05_GGTGATCT

description:
h1793_E5_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_A3_Quizartinib_0.577_24 1793PS4AA03_TGAATCAG


title: h1793_D6_DMSO_0_24 1793PS4AD06_ACACGCCA


title: h1793_E5_UNTREATED_0_24 1793PS4AE05_GGTGATCT


title: h1793_G9_Dovitinib_0.591_24 1793PS3CG09_CTGAGACG

description:
h1793_G9_Dovitinib_0.591_24
H1793_dream_counts.csv

value: Dovitinib


title: h1793_D9_Crenolanib_0.149_24 1793PS3CD09_CGCAAAAT

description:
h1793_D9_Crenolanib_0.149_24
H1793_dream_counts.csv

value: Crenolanib


title: h1793_D5_DMSO_0_24 1793PS4AD05_ACGACCTC


title: h1793_H12_MGCD265_1.082_24 1793PS3CH12_ACGACTGT

description:
h1793_H12_MGCD265_1.082_24
H1793_dream_counts.csv


title: h1793_D2_UNTREATED_0_24 1793PS5AD02_ATCATGTG


title: h1793_H8_Cediranib_0.222_24 1793PS3CH08_TCGTTAAG

description:
h1793_H8_Cediranib_0.222_24
H1793_dream_counts.csv

value: Cediranib


title: h1793_E7_Dacomitinib_0.053_24 1793PS3CE07_GACTCCCA

description:
h1793_E7_Dacomitinib_0.053_24
H1793_dream_counts.csv

value: Dacomitinib


title: h1793_H12_MGCD265_1.082_24 NCIH1793PS3AH12_ACGACTGT


title: h1793_G9_Dovitinib_0.591_24 NCIH1793PS3AG09_CTGAGACG


title: h1793_B8_Icotinib_7.664_24 1793PS3CB08_AAAGCGAG

description:
h1793_B8_Icotinib_7.664_24
H1793_dream_counts.csv

value: Icotinib


title: h1793_H8_Cediranib_0.222_24 NCIH1793PS3AH08_TCGTTAAG


title: h1793_E6_UNTREATED_0_24 1793PS3CE06_TTTCTCCC

description:
h1793_E6_UNTREATED_0_24
H1793_dream_counts.csv

value: UNTREATED


title: h1793_D6_DMSO_0_24 1793PS3CD06_ACACGCCA

description:
h1793_D6_DMSO_0_24
H1793_dream_counts.csv


title: h1793_E7_Dacomitinib_0.053_24 NCIH1793PS3AE07_GACTCCCA


title: h1793_E5_UNTREATED_0_24 1793PS3CE05_GGTGATCT


title: h1793_D5_DMSO_0_24 NCIH1793PS3AD05_ACGACCTC


title: h1793_E5_UNTREATED_0_24 NCIH1793PS3AE05_GGTGATCT


title: h1793_D9_Linifanib_1.4_24 NCIH1793PS2BD09_CGCAAAAT

description:
h1793_D9_Linifanib_1.4_24
H1793_dream_counts.csv

value: Linifanib


title: h1793_D8_MK2206_0.756_24 NCIH1793PS2BD08_CTCCCCTT

description:
h1793_D8_MK2206_0.756_24
H1793_dream_counts.csv


title: h1793_D5_DMSO_0_24 1793PS3CD05_ACGACCTC


title: h1793_F6_Bafetinib_7.6_24 NCIH1793PS2BF06_TCATTGGA

description:
h1793_F6_Bafetinib_7.6_24
H1793_dream_counts.csv

value: Bafetinib


title: h1793_E6_UNTREATED_0_24 NCIH1793PS2BE06_TTTCTCCC


title: h1793_D5_DMSO_0_24 NCIH1793PS2BD05_ACGACCTC

value: DMSO


title: h1793_E6_UNTREATED_0_24 NCIH1793PS3AE06_TTTCTCCC


title: h1793_C8_AEE788_0.175_24 NCIH1793PS3AC08_GCAACTAG

description:
h1793_C8_AEE788_0.175_24
H1793_dream_counts.csv


title: h1793_B8_Icotinib_7.664_24 NCIH1793PS3AB08_AAAGCGAG


title: h1793_D6_DMSO_0_24 NCIH1793PS3AD06_ACACGCCA


title: h1793_E12_Neratinib_0.23_24 NCIH1793PS2BE12_TATCGGTC

description:
h1793_E12_Neratinib_0.23_24
H1793_dream_counts.csv

value: Neratinib


title: h1793_G7_AZD5363_1.6_24 NCIH1793PS2BG07_GTGTGCTA

description:
h1793_G7_AZD5363_1.6_24
H1793_dream_counts.csv


title: h1793_D8_MK2206_0.756_24 NCIH1793PS2AD08_CTCCCCTT


title: h1793_F6_Bafetinib_7.6_24 NCIH1793PS2AF06_TCATTGGA


title: h1793_E7_Tivantinib_0.227_24 NCIH1793PS2BE07_GACTCCCA

description:
h1793_E7_Tivantinib_0.227_24
H1793_dream_counts.csv

value: Tivantinib


title: h1793_E6_UNTREATED_0_24 NCIH1793PS2AE06_TTTCTCCC


title: h1793_C8_AEE788_0.175_24 1793PS3CC08_GCAACTAG


title: h1793_D5_DMSO_0_24 NCIH1793PS2AD05_ACGACCTC

description:
h1793_D5_DMSO_0_24
H1793_dream_counts.csv


title: h1793_B3_Lapatinib_10_24 NCIH1793PS2AB03_CGACTTGT

description:
h1793_B3_Lapatinib_10_24
H1793_dream_counts.csv

value: Lapatinib


title: h1793_E2_Foretinib_0.116_24 NCIH1793PS2AE02_CGAGTAAA

description:
h1793_E2_Foretinib_0.116_24
H1793_dream_counts.csv

value: Foretinib

value: ATCC


title: h1793_H12_Vandetanib_8.2702_24 1793PS1BA01_ACGACTGT_96.gz

description:
h1793_H12_Vandetanib_8.2702_24
H1793_dream_counts.csv

value: Vandetanib

value: female


title: h1793_D6_DMSO_0_24 NCIH1793PS2BD06_ACACGCCA


title: h1793_E5_UNTREATED_0_24 NCIH1793PS2BE05_GGTGATCT

description:
h1793_E5_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_B7_Gefitinib_0.570597_24 1793PS1BA01_TTCACATG_50.gz

description:
h1793_B7_Gefitinib_0.570597_24
H1793_dream_counts.csv

value: Gefitinib


title: h1793_D3_KW2449_8.3_24 NCIH1793PS2BD03_TCTCTAGT

description:
h1793_D3_KW2449_8.3_24
H1793_dream_counts.csv


title: h1793_D3_KW2449_8.3_24 NCIH1793PS2AD03_TCTCTAGT


title: h1793_D9_Crenolanib_0.149_24 NCIH1793PS3AD09_CGCAAAAT

description:
h1793_D9_Crenolanib_0.149_24
H1793_dream_counts.csv


title: h1793_E12_Neratinib_0.23_24 NCIH1793PS2AE12_TATCGGTC


title: h1793_E2_Foretinib_0.116_24 NCIH1793PS2BE02_CGAGTAAA


title: h1793_B3_Lapatinib_10_24 NCIH1793PS2BB03_CGACTTGT


title: h1793_F4_Crizotinib_0.193205_24 1793PS1BA01_GTGTACAC_30.gz

description:
h1793_F4_Crizotinib_0.193205_24
H1793_dream_counts.csv

value: Crizotinib


title: h1793_G7_AZD5363_1.6_24 NCIH1793PS2AG07_GTGTGCTA


title: h1793_E7_Tivantinib_0.227_24 NCIH1793PS2AE07_GACTCCCA


title: h1793_E5_UNTREATED_0_24 NCIH1793PS2AE05_GGTGATCT


title: h1793_D3_Ponatinib_0.080426_24 1793PS1BA01_TCTCTAGT_20.gz

description:
h1793_D3_Ponatinib_0.080426_24
H1793_dream_counts.csv

value: Ponatinib


title: h1793_D6_DMSO_0_24 NCIH1793PS2AD06_ACACGCCA

description:
h1793_D6_DMSO_0_24
H1793_dream_counts.csv


title: h1793_H9_Osimertinib_1.68_24 1793PS1BA01_TGTCCCCA_72.gz

description:
h1793_H9_Osimertinib_1.68_24
H1793_dream_counts.csv

value: Osimertinib


title: h1793_G2_Sunitinib_0.048817_24 1793PS1BA01_CCTCTTAG_15.gz

description:
h1793_G2_Sunitinib_0.048817_24
H1793_dream_counts.csv

value: Sunitinib


title: h1793_H12_Vandetanib_8.2702_24 1793PS1AA01_ACGACTGT_96.gz


title: h1793_B12_Regorafenib_5.177913_24 1793PS1BA01_TTGGAAAC_90.gz

description:
h1793_B12_Regorafenib_5.177913_24
H1793_dream_counts.csv

value: Regorafenib


title: h1793_G8_Cabozantinib_1.094376_24 1793PS1BA01_TGTTACGT_63.gz

description:
h1793_G8_Cabozantinib_1.094376_24
H1793_dream_counts.csv

value: Cabozantinib


title: h1793_A12_Sorafenib_4.948046_24 1793PS1BA01_TGGCTCTA_89.gz

description:
h1793_A12_Sorafenib_4.948046_24
H1793_dream_counts.csv

value: Sorafenib


title: h1793_D9_Linifanib_1.4_24 NCIH1793PS2AD09_CGCAAAAT

description:
h1793_D9_Linifanib_1.4_24
H1793_dream_counts.csv

value: Linifanib


title: h1793_C12_Imatinib_5.455337_24 1793PS1AA01_TAGCATAC_91.gz

description:
h1793_C12_Imatinib_5.455337_24
H1793_dream_counts.csv

value: Imatinib


title: h1793_E5_UNTREATED_0_24 1793PS1BA01_GGTGATCT_37.gz

value: UNTREATED


title: h1793_G10_Nilotinib_2.2942_24 1793PS1BA01_CCAGGCAA_79.gz

description:
h1793_G10_Nilotinib_2.2942_24
H1793_dream_counts.csv

value: Nilotinib


title: h1793_B12_Regorafenib_5.177913_24 1793PS1AA01_TTGGAAAC_90.gz


title: h1793_F6_Bosutinib_0.377074_24 1793PS1BA01_TCATTGGA_46.gz

description:
h1793_F6_Bosutinib_0.377074_24
H1793_dream_counts.csv

value: Bosutinib


title: h1793_H9_Osimertinib_1.68_24 1793PS1AA01_TGTCCCCA_72.gz


title: h1793_B6_Dasatinib_0.345485_24 1793PS1BA01_CTTCGTCT_42.gz

description:
h1793_B6_Dasatinib_0.345485_24
H1793_dream_counts.csv

value: Dasatinib


title: h1793_E6_UNTREATED_0_24 1793PS1BA01_TTTCTCCC_45.gz

description:
h1793_E6_UNTREATED_0_24
H1793_dream_counts.csv

value: ATCC


title: h1793_F6_Bosutinib_0.377074_24 1793PS1AA01_TCATTGGA_46.gz


title: h1793_E6_UNTREATED_0_24 1793PS1AA01_TTTCTCCC_45.gz


title: h1793_E4_Afatinib_0.186854_24 1793PS1BA01_CCAGATAC_29.gz

description:
h1793_E4_Afatinib_0.186854_24
H1793_dream_counts.csv

value: Afatinib


title: h1793_D6_DMSO_0_24 1793PS1AA01_ACACGCCA_44.gz

value: DMSO

value: female


title: h1793_D5_DMSO_0_24 1793PS1BA01_ACGACCTC_36.gz

description:
h1793_D5_DMSO_0_24
H1793_dream_counts.csv


title: h1793_C12_Imatinib_5.455337_24 1793PS1BA01_TAGCATAC_91.gz


title: h1793_D3_Ponatinib_0.080426_24 1793PS1AA01_TCTCTAGT_20.gz


title: h1793_G2_Sunitinib_0.048817_24 1793PS1AA01_CCTCTTAG_15.gz


title: h1793_D6_DMSO_0_24 1793PS1BA01_ACACGCCA_44.gz


title: efo21_F11_DMSO__24 EFO21PS4BS359_ATGCCATT

description:
efo21_F11_DMSO__24
EFO21_dream_counts.csv

source_name: ovarian cancer

value: DSMZ

value: ACC 235


title: efo21_E06_UNTREATED__24 EFO21PS4BS342_GGAACTCA

description:
efo21_E06_UNTREATED__24
EFO21_dream_counts.csv


title: h1793_G8_Cabozantinib_1.094376_24 1793PS1AA01_TGTTACGT_63.gz


title: h1793_A12_Sorafenib_4.948046_24 1793PS1AA01_TGGCTCTA_89.gz


title: h1793_G10_Nilotinib_2.2942_24 1793PS1AA01_CCAGGCAA_79.gz


title: h1793_B7_Gefitinib_0.570597_24 1793PS1AA01_TTCACATG_50.gz

description:
h1793_B7_Gefitinib_0.570597_24
H1793_dream_counts.csv

value: Gefitinib


title: h1793_B6_Dasatinib_0.345485_24 1793PS1AA01_CTTCGTCT_42.gz


title: efo21_C02_UNTREATED__24 EFO21PS4BS314_TAAGTCGC

description:
efo21_C02_UNTREATED__24
EFO21_dream_counts.csv


title: efo21_C06_DMSO__24 EFO21PS4BS318_AACGGTAC

description:
efo21_C06_DMSO__24
EFO21_dream_counts.csv


title: efo21_A02_DMSO__24 EFO21PS4BS290_CTATACCA

description:
efo21_A02_DMSO__24
EFO21_dream_counts.csv


title: h1793_E5_UNTREATED_0_24 1793PS1AA01_GGTGATCT_37.gz

description:
h1793_E5_UNTREATED_0_24
H1793_dream_counts.csv


title: h1793_D5_DMSO_0_24 1793PS1AA01_ACGACCTC_36.gz


title: h1793_F4_Crizotinib_0.193205_24 1793PS1AA01_GTGTACAC_30.gz

description:
h1793_F4_Crizotinib_0.193205_24
H1793_dream_counts.csv

value: Crizotinib


title: h1793_E4_Afatinib_0.186854_24 1793PS1AA01_CCAGATAC_29.gz


title: efo21_H11_UNTREATED__24 EFO21PS4BS383_AAGTGGAT

description:
efo21_H11_UNTREATED__24
EFO21_dream_counts.csv


title: efo21_D06_DMSO__24 EFO21PS4BS330_GAGTGTAG

description:
efo21_D06_DMSO__24
EFO21_dream_counts.csv


title: efo21_D02_UNTREATED__24 EFO21PS4AS230_TGACATGC

description:
efo21_D02_UNTREATED__24
EFO21_dream_counts.csv


title: efo21_C06_DMSO__24 EFO21PS4AS222_AACCATCC


title: efo21_C02_UNTREATED__24 EFO21PS4AS218_AATTCGTC


title: efo21_D02_UNTREATED__24 EFO21PS4BS326_CATGAAGA


title: efo21_F06_UNTREATED__24 EFO21PS4BS354_TAGGAGAT

description:
efo21_F06_UNTREATED__24
EFO21_dream_counts.csv


title: efo21_G11_UNTREATED__24 EFO21PS4AS275_GCCTCGAT

description:
efo21_G11_UNTREATED__24
EFO21_dream_counts.csv


title: efo21_H11_UNTREATED_0_24 EFO21PS3BS767_ACAAGTCT

description:
efo21_H11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_E11_DMSO__24 EFO21PS4BS347_GAACAGAC

description:
efo21_E11_DMSO__24
EFO21_dream_counts.csv


title: efo21_H11_UNTREATED__24 EFO21PS4AS287_GCACTAAT


title: efo21_B02_DMSO__24 EFO21PS4BS302_CATTTGCA

description:
efo21_B02_DMSO__24
EFO21_dream_counts.csv


title: efo21_G11_UNTREATED__24 EFO21PS4BS371_GTGCGAAG


title: efo21_E11_DMSO__24 EFO21PS4AS251_GGAAAAGC


title: efo21_D06_DMSO__24 EFO21PS4AS234_TGCGTCTT


title: efo21_F11_DMSO__24 EFO21PS4AS263_ATCGATTC


title: efo21_F07_MGCD265_1_24 EFO21PS3BS739_CCAGAAGG

description:
efo21_F07_MGCD265_1_24
EFO21_dream_counts.csv


title: efo21_B02_DMSO__24 EFO21PS4AS206_GTCCGTTG


title: efo21_E06_UNTREATED__24 EFO21PS4AS246_CACCTCTC


title: efo21_A02_DMSO__24 EFO21PS4AS194_GAGCTGGT


title: efo21_E11_DMSO_0_24 EFO21PS3BS731_CACCCTAC

description:
efo21_E11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_H07_Quizartinib_1.5_24 EFO21PS3BS763_CGATAGCC

description:
efo21_H07_Quizartinib_1.5_24
EFO21_dream_counts.csv

value: Quizartinib


title: efo21_G11_UNTREATED_0_24 EFO21PS3BS755_GGGCTTCT

description:
efo21_G11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D12_Tivantinib_1.5_24 EFO21PS3BS720_GCGTAGGA

description:
efo21_D12_Tivantinib_1.5_24
EFO21_dream_counts.csv

value: Tivantinib


title: efo21_E04_Cediranib_0.22_24 EFO21PS3BS724_CCTATGCC

description:
efo21_E04_Cediranib_0.22_24
EFO21_dream_counts.csv

value: Cediranib


title: efo21_G06_Crenolanib_0.145_24 EFO21PS3BS750_TGTTTGCT

description:
efo21_G06_Crenolanib_0.145_24
EFO21_dream_counts.csv

value: Crenolanib


title: efo21_D06_DMSO_0_24 EFO21PS3BS714_CTGTGAGT

description:
efo21_D06_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_G01_AEE788_0.17_24 EFO21PS3BS745_TATGCAGC

description:
efo21_G01_AEE788_0.17_24
EFO21_dream_counts.csv


title: efo21_F06_UNTREATED__24 EFO21PS4AS258_TCCCTGAC


title: efo21_F04_Varlitinib_1_24 EFO21PS3BS736_AGTCATTC

description:
efo21_F04_Varlitinib_1_24
EFO21_dream_counts.csv

value: Varlitinib


title: efo21_G03_Dacomitinib_0.05_24 EFO21PS3BS747_AGCACTAC

description:
efo21_G03_Dacomitinib_0.05_24
EFO21_dream_counts.csv

value: Dacomitinib


title: efo21_F11_DMSO_0_24 EFO21PS3BS743_GTGATGAC

description:
efo21_F11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_A02_DMSO_0_24 EFO21PS3BS674_GGAGGGAA

description:
efo21_A02_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_G11_UNTREATED_0_24 EFO21PS3AS659_ATACGCAT

value: UNTREATED


title: efo21_F01_Icotinib_7.5_24 EFO21PS3BS733_AATCGAGA

description:
efo21_F01_Icotinib_7.5_24
EFO21_dream_counts.csv

value: Icotinib


title: efo21_F06_UNTREATED_0_24 EFO21PS3BS738_GCTTACCA

description:
efo21_F06_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D07_Dovitinib_0.5_24 EFO21PS3BS715_CGAATCTT

description:
efo21_D07_Dovitinib_0.5_24
EFO21_dream_counts.csv

value: Dovitinib


title: efo21_F07_MGCD265_1_24 EFO21PS3AS643_CGACAACA


title: efo21_D02_UNTREATED_0_24 EFO21PS3BS710_GCTGCGTA

description:
efo21_D02_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_E06_UNTREATED_0_24 EFO21PS3BS726_ATTCACAG

description:
efo21_E06_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_F06_UNTREATED_0_24 EFO21PS3AS642_AGATAGGT


title: efo21_C06_DMSO_0_24 EFO21PS3BS702_TCCAGCAA

description:
efo21_C06_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_C02_UNTREATED_0_24 EFO21PS3BS698_AGCAGCGT

description:
efo21_C02_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_F04_Varlitinib_1_24 EFO21PS3AS640_CATCAGAT


title: efo21_H11_UNTREATED_0_24 EFO21PS3AS671_TAACCCGA

description:
efo21_H11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D07_Dovitinib_0.5_24 EFO21PS3AS619_AGGCACGT


title: efo21_E11_DMSO_0_24 EFO21PS3AS635_GAGAGAAA

description:
efo21_E11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_F11_DMSO_0_24 EFO21PS3AS647_CTGCCAAC


title: efo21_E04_Cediranib_0.22_24 EFO21PS3AS628_CTCCCTGA

description:
efo21_E04_Cediranib_0.22_24
EFO21_dream_counts.csv


title: efo21_G01_AEE788_0.17_24 EFO21PS3AS649_GCGTGATG


title: efo21_G06_Crenolanib_0.145_24 EFO21PS3AS654_CGTCATAA

description:
efo21_G06_Crenolanib_0.145_24
EFO21_dream_counts.csv


title: efo21_D02_UNTREATED_0_24 EFO21PS3AS614_GGCGTTCA


title: efo21_C06_DMSO_0_24 EFO21PS3AS606_TATGGCCA


title: efo21_B02_DMSO_0_24 EFO21PS3AS590_CGTGTAGG

description:
efo21_B02_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_F01_Icotinib_7.5_24 EFO21PS3AS637_TTCTGTGG


title: efo21_D12_Tivantinib_1.5_24 EFO21PS3AS624_GAGTCGTT

description:
efo21_D12_Tivantinib_1.5_24
EFO21_dream_counts.csv


title: efo21_B02_DMSO_0_24 EFO21PS3BS686_CTAATCCC


title: efo21_E06_UNTREATED_0_24 EFO21PS3AS630_AACTTGGC


title: efo21_G5_AZD5363_7_24 EFO21PS2BS173_TGTATTCG

description:
efo21_G5_AZD5363_7_24
EFO21_dream_counts.csv


title: efo21_G10_Sunitinib_4.5_24 EFO21PS2BS178_ATGTAGTG

description:
efo21_G10_Sunitinib_4.5_24
EFO21_dream_counts.csv

value: Sunitinib


title: efo21_H07_Quizartinib_1.5_24 EFO21PS3AS667_TCGATTAC

description:
efo21_H07_Quizartinib_1.5_24
EFO21_dream_counts.csv


title: efo21_D06_DMSO_0_24 EFO21PS3AS618_GTTGTTGT

description:
efo21_D06_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_A02_DMSO_0_24 EFO21PS3AS578_AGACGTTT

description:
efo21_A02_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_C02_UNTREATED_0_24 EFO21PS3AS602_GAGGTCTT


title: efo21_F9_MK2206_3_24 EFO21PS2BS165_CCAAAATC

description:
efo21_F9_MK2206_3_24
EFO21_dream_counts.csv


title: efo21_G03_Dacomitinib_0.05_24 EFO21PS3AS651_ATAGCCTA

description:
efo21_G03_Dacomitinib_0.05_24
EFO21_dream_counts.csv


title: efo21_H12_Ponatinib_13.5_24 EFO21PS2BS192_TTGTTCGC

description:
efo21_H12_Ponatinib_13.5_24
EFO21_dream_counts.csv

value: Ponatinib


title: efo21_F6_UNTREATED_0_24 EFO21PS2BS162_CTCTTACG

description:
efo21_F6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_F8_Linifanib_1.5_24 EFO21PS2BS164_GGCCTGAA

description:
efo21_F8_Linifanib_1.5_24
EFO21_dream_counts.csv

value: Linifanib


title: efo21_E4_Vandetanib_29_24 EFO21PS2BS148_CATTAACG

description:
efo21_E4_Vandetanib_29_24
EFO21_dream_counts.csv

value: Vandetanib

value: female


title: efo21_D2_UNTREATED_0_24 EFO21PS2BS134_TATGCGTG

description:
efo21_D2_UNTREATED_0_24
EFO21_dream_counts.csv

value: DSMZ

value: ACC 235


title: efo21_H11_UNTREATED_0_24 EFO21PS2BS191_TGTCGTGA

description:
efo21_H11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D3_Regorafenib_5_24 EFO21PS2BS135_TCAAGGTT

description:
efo21_D3_Regorafenib_5_24
EFO21_dream_counts.csv

value: Regorafenib


title: efo21_E6_UNTREATED_0_24 EFO21PS2BS150_CACTCCTG

description:
efo21_E6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_H6_Bafetinib_8.5_24 EFO21PS2BS186_GAATGCTT

description:
efo21_H6_Bafetinib_8.5_24
EFO21_dream_counts.csv

value: Bafetinib


title: efo21_C8_KW2449_8_24 EFO21PS2BS128_GGTCAAAC

description:
efo21_C8_KW2449_8_24
EFO21_dream_counts.csv


title: efo21_F11_DMSO_0_24 EFO21PS2BS167_GCTAAGAC

description:
efo21_F11_DMSO_0_24
EFO21_dream_counts.csv

value: DMSO


title: efo21_G11_UNTREATED_0_24 EFO21PS2BS179_TTCAGAGT

description:
efo21_G11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_H9_Foretinib_20_24 EFO21PS2BS189_TTACGTGT

description:
efo21_H9_Foretinib_20_24
EFO21_dream_counts.csv

value: Foretinib


title: efo21_E11_DMSO_0_24 EFO21PS2BS155_TATACGCT

description:
efo21_E11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_D10_Neratinib_16.5_24 EFO21PS2BS142_TTCTGCTC

description:
efo21_D10_Neratinib_16.5_24
EFO21_dream_counts.csv

value: Neratinib


title: efo21_B2_DMSO_0_24 EFO21PS2BS110_CTGAGGTC

description:
efo21_B2_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_C6_DMSO_0_24 EFO21PS2BS126_CTGGTCAT

description:
efo21_C6_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_H12_Ponatinib_13.5_24 EFO21PS2AS96_ACGACTGT

description:
efo21_H12_Ponatinib_13.5_24
EFO21_dream_counts.csv


title: efo21_B11_Sorafenib_4.5_24 EFO21PS2BS119_ATGCTCGA

description:
efo21_B11_Sorafenib_4.5_24
EFO21_dream_counts.csv

value: Sorafenib


title: efo21_G11_UNTREATED_0_24 EFO21PS2AS83_GTCGCACA


title: efo21_H11_UNTREATED_0_24 EFO21PS2AS95_CGGTGATA


title: efo21_H9_Foretinib_20_24 EFO21PS2AS93_TGTCCCCA


title: efo21_C2_UNTREATED_0_24 EFO21PS2BS122_TGTCAACG

description:
efo21_C2_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D6_DMSO_0_24 EFO21PS2BS138_AGACAGTG

description:
efo21_D6_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_A2_DMSO_0_24 EFO21PS2BS98_ACATGTTG

description:
efo21_A2_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_H6_Bafetinib_8.5_24 EFO21PS2AS90_TCCTGTCA


title: efo21_D6_DMSO_0_24 EFO21PS2AS42_ACACGCCA


title: efo21_G10_Sunitinib_4.5_24 EFO21PS2AS82_CCAGGCAA

description:
efo21_G10_Sunitinib_4.5_24
EFO21_dream_counts.csv


title: efo21_F9_MK2206_3_24 EFO21PS2AS69_CAGTTCGG

description:
efo21_F9_MK2206_3_24
EFO21_dream_counts.csv


title: efo21_D3_Regorafenib_5_24 EFO21PS2AS39_TCTCTAGT

description:
efo21_D3_Regorafenib_5_24
EFO21_dream_counts.csv


title: efo21_F8_Linifanib_1.5_24 EFO21PS2AS68_GAATTGTG

description:
efo21_F8_Linifanib_1.5_24
EFO21_dream_counts.csv


title: efo21_G5_AZD5363_7_24 EFO21PS2AS77_GCAAGACG

description:
efo21_G5_AZD5363_7_24
EFO21_dream_counts.csv


title: efo21_F11_DMSO_0_24 EFO21PS2AS71_ATTGTGGC

description:
efo21_F11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_C2_UNTREATED_0_24 EFO21PS2AS26_TTTTACCG


title: efo21_B11_Sorafenib_4.5_24 EFO21PS2AS23_CCCAAACA


title: efo21_D10_Neratinib_16.5_24 EFO21PS2AS46_GTTAGCGT


title: efo21_C6_DMSO_0_24 EFO21PS2AS30_AACAGTTG


title: efo21_E6_UNTREATED_0_24 EFO21PS2AS54_TTTCTCCC

description:
efo21_E6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_D2_UNTREATED_0_24 EFO21PS2AS38_ATCATGTG

description:
efo21_D2_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_H3_Lapatinib_10_24 EFO21PS1BS759_TTGGGTTT

description:
efo21_H3_Lapatinib_10_24
EFO21_dream_counts.csv

value: Lapatinib


title: efo21_E4_Vandetanib_29_24 EFO21PS2AS52_CCAGATAC

description:
efo21_E4_Vandetanib_29_24
EFO21_dream_counts.csv


title: efo21_A2_DMSO_0_24 EFO21PS2AS2_CGTTGTCA


title: efo21_C8_KW2449_8_24 EFO21PS2AS32_GCAACTAG

description:
efo21_C8_KW2449_8_24
EFO21_dream_counts.csv


title: efo21_E11_DMSO_0_24 EFO21PS2AS59_CTAGCATC

description:
efo21_E11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_H6_Crizotinib_0.19_24 EFO21PS1BS762_TACTGCCT

description:
efo21_H6_Crizotinib_0.19_24
EFO21_dream_counts.csv

value: Crizotinib


title: efo21_G11_UNTREATED_0_24 EFO21PS1BS755_GGGCTTCT

description:
efo21_G11_UNTREATED_0_24
EFO21_dream_counts.csv

value: UNTREATED


title: efo21_F6_UNTREATED_0_24 EFO21PS2AS66_TCATTGGA

description:
efo21_F6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_F6_UNTREATED_0_24 EFO21PS1BS738_GCTTACCA


title: efo21_G10_Dasatinib_0.025_24 EFO21PS1BS754_TGAAGTAC

description:
efo21_G10_Dasatinib_0.025_24
EFO21_dream_counts.csv

value: Dasatinib


title: efo21_F11_DMSO_0_24 EFO21PS1BS743_GTGATGAC


title: efo21_E11_DMSO_0_24 EFO21PS1BS731_CACCCTAC


title: efo21_G12_Bosutinib_0.375_24 EFO21PS1BS756_CAGCTTAA

description:
efo21_G12_Bosutinib_0.375_24
EFO21_dream_counts.csv

value: Bosutinib


title: efo21_E9_Osimertinib_1_24 EFO21PS1BS729_AGCATGCC

description:
efo21_E9_Osimertinib_1_24
EFO21_dream_counts.csv

value: Osimertinib


title: efo21_E6_UNTREATED_0_24 EFO21PS1BS726_ATTCACAG


title: efo21_H11_UNTREATED_0_24 EFO21PS1BS767_ACAAGTCT

description:
efo21_H11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_B2_DMSO_0_24 EFO21PS2AS14_CAGTACCT

description:
efo21_B2_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_D6_DMSO_0_24 EFO21PS1BS714_CTGTGAGT

description:
efo21_D6_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_H10_Afatinib_0.1_24 EFO21PS1BS766_AGCGACCT

description:
efo21_H10_Afatinib_0.1_24
EFO21_dream_counts.csv

value: Afatinib


title: efo21_C9_Cabozantinib_1_24 EFO21PS1BS705_TCCAATGA

description:
efo21_C9_Cabozantinib_1_24
EFO21_dream_counts.csv

value: Cabozantinib


title: efo21_D7_Nilotinib_2.5_24 EFO21PS1BS715_CGAATCTT

description:
efo21_D7_Nilotinib_2.5_24
EFO21_dream_counts.csv

value: Nilotinib

value: female


title: efo21_D2_UNTREATED_0_24 EFO21PS1BS710_GCTGCGTA

description:
efo21_D2_UNTREATED_0_24
EFO21_dream_counts.csv

value: DSMZ

value: ACC 235


title: efo21_B3_Gefitinib_0.5_24 EFO21PS1BS687_CACGGACT

description:
efo21_B3_Gefitinib_0.5_24
EFO21_dream_counts.csv

value: Gefitinib


title: efo21_C2_UNTREATED_0_24 EFO21PS1BS698_AGCAGCGT

description:
efo21_C2_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_C6_DMSO_0_24 EFO21PS1BS702_TCCAGCAA

description:
efo21_C6_DMSO_0_24
EFO21_dream_counts.csv

value: DMSO


title: efo21_B2_DMSO_0_24 EFO21PS1BS686_CTAATCCC


title: efo21_H11_UNTREATED_0_24 EFO21PS1AS671_TAACCCGA


title: efo21_H3_Lapatinib_10_24 EFO21PS1AS663_ACCCATTA

description:
efo21_H3_Lapatinib_10_24
EFO21_dream_counts.csv


title: efo21_H6_Crizotinib_0.19_24 EFO21PS1AS666_AGCTAGAC

description:
efo21_H6_Crizotinib_0.19_24
EFO21_dream_counts.csv


title: efo21_G11_UNTREATED_0_24 EFO21PS1AS659_ATACGCAT

description:
efo21_G11_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_G12_Bosutinib_0.375_24 EFO21PS1AS660_TACCTGCT


title: efo21_G10_Dasatinib_0.025_24 EFO21PS1AS658_TTTGACGC


title: efo21_F11_DMSO_0_24 EFO21PS1AS647_CTGCCAAC

description:
efo21_F11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_F6_UNTREATED_0_24 EFO21PS1AS642_AGATAGGT

description:
efo21_F6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_E7_Imatinib_5_24 EFO21PS1BS727_TTTCGACA

description:
efo21_E7_Imatinib_5_24
EFO21_dream_counts.csv

value: Imatinib


title: efo21_E6_UNTREATED_0_24 EFO21PS1AS630_AACTTGGC

description:
efo21_E6_UNTREATED_0_24
EFO21_dream_counts.csv


title: efo21_E11_DMSO_0_24 EFO21PS1AS635_GAGAGAAA

description:
efo21_E11_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_E9_Osimertinib_1_24 EFO21PS1AS633_CCACCATG

description:
efo21_E9_Osimertinib_1_24
EFO21_dream_counts.csv


title: efo21_E7_Imatinib_5_24 EFO21PS1AS631_TCGGATGT


title: efo21_D2_UNTREATED_0_24 EFO21PS1AS614_GGCGTTCA


title: efo21_D7_Nilotinib_2.5_24 EFO21PS1AS619_AGGCACGT


title: efo21_C9_Cabozantinib_1_24 EFO21PS1AS609_TAACAACC


title: efo21_B2_DMSO_0_24 EFO21PS1AS590_CGTGTAGG

description:
efo21_B2_DMSO_0_24
EFO21_dream_counts.csv


title: efo21_C6_DMSO_0_24 EFO21PS1AS606_TATGGCCA


title: efo21_C2_UNTREATED_0_24 EFO21PS1AS602_GAGGTCTT


title: efo21_H10_Afatinib_0.1_24 EFO21PS1AS670_TAGCTTCG

description:
efo21_H10_Afatinib_0.1_24
EFO21_dream_counts.csv


title: efo21_A2_DMSO_0_24 EFO21PS1BS674_GGAGGGAA

description:
efo21_A2_DMSO_0_24
EFO21_dream_counts.csv


title: du145_H11_UNTREATED__24 DU145PS4BS671_TAACCCGA

description:
du145_H11_UNTREATED__24
DU145_dream_counts.csv

source_name: prostate cancer

value: ATCC

value: male


title: du145_F11_DMSO_0_24 DU145PS4BS647_CTGCCAAC

description:
du145_F11_DMSO_0_24
DU145_dream_counts.csv


title: efo21_B3_Gefitinib_0.5_24 EFO21PS1AS591_TAAAGGCC

description:
efo21_B3_Gefitinib_0.5_24
EFO21_dream_counts.csv


title: du145_G11_UNTREATED__24 DU145PS4BS659_ATACGCAT

description:
du145_G11_UNTREATED__24
DU145_dream_counts.csv


title: du145_E11_DMSO_0_24 DU145PS4BS635_GAGAGAAA

description:
du145_E11_DMSO_0_24
DU145_dream_counts.csv


title: du145_E06_UNTREATED__24 DU145PS4BS630_AACTTGGC

description:
du145_E06_UNTREATED__24
DU145_dream_counts.csv


title: du145_F06_UNTREATED__24 DU145PS4BS642_AGATAGGT

description:
du145_F06_UNTREATED__24
DU145_dream_counts.csv


title: du145_D06_DMSO_0_24 DU145PS4BS618_GTTGTTGT

description:
du145_D06_DMSO_0_24
DU145_dream_counts.csv


title: du145_C02_UNTREATED__24 DU145PS4BS602_GAGGTCTT

description:
du145_C02_UNTREATED__24
DU145_dream_counts.csv


title: du145_C06_DMSO_0_24 DU145PS4BS606_TATGGCCA

description:
du145_C06_DMSO_0_24
DU145_dream_counts.csv


title: du145_B02_DMSO_0_24 DU145PS4BS590_CGTGTAGG

description:
du145_B02_DMSO_0_24
DU145_dream_counts.csv


title: du145_A02_DMSO_0_24 DU145PS4BS578_AGACGTTT

description:
du145_A02_DMSO_0_24
DU145_dream_counts.csv


title: du145_E11_DMSO_0_24 DU145PS4AS539_GACAGTCT


title: du145_G11_UNTREATED__24 DU145PS4AS563_ATAGGGCG


title: efo21_D6_DMSO_0_24 EFO21PS1AS618_GTTGTTGT

description:
efo21_D6_DMSO_0_24
EFO21_dream_counts.csv


title: du145_H11_UNTREATED__24 DU145PS4AS575_AGAGTGTC


title: du145_F06_UNTREATED__24 DU145PS4AS546_CGAAGAGT


title: du145_F11_DMSO_0_24 DU145PS4AS551_TAGGTTTC


title: du145_E06_UNTREATED__24 DU145PS4AS534_ACTATCTG


title: du145_D06_DMSO_0_24 DU145PS4AS522_GAAGTCCA


title: du145_D02_UNTREATED__24 DU145PS4AS518_GACGACTC

description:
du145_D02_UNTREATED__24
DU145_dream_counts.csv


title: du145_C06_DMSO_0_24 DU145PS4AS510_ACCGCTAG


title: du145_D02_UNTREATED__24 DU145PS4BS614_GGCGTTCA


title: du145_F11_DMSO__24 DU145PS3BS455_CACTTGAT

description:
du145_F11_DMSO__24
DU145_dream_counts.csv


title: du145_H11_UNTREATED__24 DU145PS3BS479_GCGACGAA


title: du145_A02_DMSO_0_24 DU145PS4AS482_CGAAGCCA


title: du145_G11_UNTREATED__24 DU145PS3BS467_TCACAAGA


title: du145_C02_UNTREATED__24 DU145PS4AS506_CCCCTTCA


title: du145_F08_Quizartinib_1.5_24 DU145PS3BS452_AGTGGCAA

description:
du145_F08_Quizartinib_1.5_24
DU145_dream_counts.csv

value: Quizartinib


title: du145_F04_Dacomitinib_0.001_24 DU145PS3BS448_CAGTAATC

description:
du145_F04_Dacomitinib_0.001_24
DU145_dream_counts.csv

value: Dacomitinib


title: du145_B02_DMSO_0_24 DU145PS4AS494_GACTGAGG


title: du145_E07_Crenolanib_0.145_24 DU145PS3BS439_ATGTCGAC

description:
du145_E07_Crenolanib_0.145_24
DU145_dream_counts.csv

value: Crenolanib


title: du145_E11_DMSO__24 DU145PS3BS443_AATGGCGT

description:
du145_E11_DMSO__24
DU145_dream_counts.csv


title: du145_E05_Varlitinib_0.005_24 DU145PS3BS437_CGCAATGC

description:
du145_E05_Varlitinib_0.005_24
DU145_dream_counts.csv

value: Varlitinib


title: du145_D05_Cediranib_0.22_24 DU145PS3BS425_AGATCATC

description:
du145_D05_Cediranib_0.22_24
DU145_dream_counts.csv

value: Cediranib


title: du145_E06_UNTREATED__24 DU145PS3BS438_CTGACGGT

value: UNTREATED


title: du145_C06_DMSO__24 DU145PS3BS414_TGGTGGTG

description:
du145_C06_DMSO__24
DU145_dream_counts.csv


title: du145_D02_UNTREATED__24 DU145PS3BS422_ACGTGGCA


title: efo21_A2_DMSO_0_24 EFO21PS1AS578_AGACGTTT

description:
efo21_A2_DMSO_0_24
EFO21_dream_counts.csv


title: du145_C02_UNTREATED__24 DU145PS3BS410_CCGGCTAT


title: du145_B08_Dovitinib_0.31_24 DU145PS3BS404_GGCTCATT

description:
du145_B08_Dovitinib_0.31_24
DU145_dream_counts.csv

value: Dovitinib


title: du145_D06_DMSO__24 DU145PS3BS426_TCGTCGCT

description:
du145_D06_DMSO__24
DU145_dream_counts.csv


title: du145_B03_AEE788_0.17_24 DU145PS3BS399_GGACTGTT

description:
du145_B03_AEE788_0.17_24
DU145_dream_counts.csv


title: du145_A02_DMSO__24 DU145PS3BS386_GTAACGCT

description:
du145_A02_DMSO__24
DU145_dream_counts.csv


title: du145_B02_DMSO__24 DU145PS3BS398_GGGAGATT

description:
du145_B02_DMSO__24
DU145_dream_counts.csv


title: du145_H11_UNTREATED__24 DU145PS3AS383_AAGTGGAT

description:
du145_H11_UNTREATED__24
DU145_dream_counts.csv


title: du145_F11_DMSO_0_24 DU145PS3AS359_ATGCCATT

description:
du145_F11_DMSO_0_24
DU145_dream_counts.csv


title: du145_F06_UNTREATED__24 DU145PS3BS450_GTGATAGT

description:
du145_F06_UNTREATED__24
DU145_dream_counts.csv


title: du145_G11_UNTREATED__24 DU145PS3AS371_GTGCGAAG

description:
du145_G11_UNTREATED__24
DU145_dream_counts.csv


title: du145_F08_Quizartinib_1.5_24 DU145PS3AS356_GATACAGT

description:
du145_F08_Quizartinib_1.5_24
DU145_dream_counts.csv


title: du145_D08_MGCD265_1_24 DU145PS3BS428_TTAGAGCC

description:
du145_D08_MGCD265_1_24
DU145_dream_counts.csv


title: du145_F04_Dacomitinib_0.001_24 DU145PS3AS352_CGTGACAC

description:
du145_F04_Dacomitinib_0.001_24
DU145_dream_counts.csv


title: du145_D08_MGCD265_1_24 DU145PS3AS332_CCATGATT


title: du145_E07_Crenolanib_0.145_24 DU145PS3AS343_ACGAAAGC

description:
du145_E07_Crenolanib_0.145_24
DU145_dream_counts.csv


title: du145_E05_Varlitinib_0.005_24 DU145PS3AS341_TTGGCAGT

description:
du145_E05_Varlitinib_0.005_24
DU145_dream_counts.csv


title: du145_E06_UNTREATED__24 DU145PS3AS342_GGAACTCA

description:
du145_E06_UNTREATED__24
DU145_dream_counts.csv


title: du145_F06_UNTREATED__24 DU145PS3AS354_TAGGAGAT


title: du145_D06_DMSO_0_24 DU145PS3AS330_GAGTGTAG

description:
du145_D06_DMSO_0_24
DU145_dream_counts.csv


title: du145_E11_DMSO_0_24 DU145PS3AS347_GAACAGAC

description:
du145_E11_DMSO_0_24
DU145_dream_counts.csv


title: du145_C02_UNTREATED__24 DU145PS3AS314_TAAGTCGC

description:
du145_C02_UNTREATED__24
DU145_dream_counts.csv


title: du145_D02_UNTREATED__24 DU145PS3AS326_CATGAAGA

description:
du145_D02_UNTREATED__24
DU145_dream_counts.csv


title: du145_A03_Icotinib_1_24 DU145PS3BS387_GGAGTCAT

description:
du145_A03_Icotinib_1_24
DU145_dream_counts.csv

value: Icotinib


title: du145_D05_Cediranib_0.22_24 DU145PS3AS329_TGTCGCAG

description:
du145_D05_Cediranib_0.22_24
DU145_dream_counts.csv


title: du145_C06_DMSO_0_24 DU145PS3AS318_AACGGTAC

description:
du145_C06_DMSO_0_24
DU145_dream_counts.csv


title: du145_B03_AEE788_0.17_24 DU145PS3AS303_AAGGCCTG

description:
du145_B03_AEE788_0.17_24
DU145_dream_counts.csv


title: du145_B02_DMSO_0_24 DU145PS3AS302_CATTTGCA

description:
du145_B02_DMSO_0_24
DU145_dream_counts.csv


title: du145_A02_DMSO_0_24 DU145PS3AS290_CTATACCA

description:
du145_A02_DMSO_0_24
DU145_dream_counts.csv


title: du145_A03_Icotinib_1_24 DU145PS3AS291_TGCCGATC


title: du145_B08_Dovitinib_0.31_24 DU145PS3AS308_TCTCGTCC

description:
du145_B08_Dovitinib_0.31_24
DU145_dream_counts.csv


title: du145_F11_DMSO__24 DU145PS2BS263_ATCGATTC

description:
du145_F11_DMSO__24
DU145_dream_counts.csv


title: du145_H06_AZD5363_0.5_24 DU145PS2BS282_GACGGGTT

description:
du145_H06_AZD5363_0.5_24
DU145_dream_counts.csv


title: du145_G11_UNTREATED__24 DU145PS2BS275_GCCTCGAT

description:
du145_G11_UNTREATED__24
DU145_dream_counts.csv


title: du145_F06_UNTREATED__24 DU145PS2BS258_TCCCTGAC

description:
du145_F06_UNTREATED__24
DU145_dream_counts.csv


title: du145_H11_UNTREATED__24 DU145PS2BS287_GCACTAAT

description:
du145_H11_UNTREATED__24
DU145_dream_counts.csv


title: du145_G12_Bosutinib_0.375_24 DU145PS2BS276_CCGAAGTT

description:
du145_G12_Bosutinib_0.375_24
DU145_dream_counts.csv

value: Bosutinib


title: du145_F08_Tivantinib_0.5_24 DU145PS2BS260_AGTTTTCC

description:
du145_F08_Tivantinib_0.5_24
DU145_dream_counts.csv

value: Tivantinib


title: du145_E08_Linifanib_1_24 DU145PS2BS248_ACATCAAG

description:
du145_E08_Linifanib_1_24
DU145_dream_counts.csv

value: Linifanib


title: du145_E09_Neratinib_0.225_24 DU145PS2BS249_GGCTTGGT

description:
du145_E09_Neratinib_0.225_24
DU145_dream_counts.csv

value: Neratinib


title: du145_E11_DMSO__24 DU145PS2BS251_GGAAAAGC

description:
du145_E11_DMSO__24
DU145_dream_counts.csv


title: du145_D06_DMSO__24 DU145PS2BS234_TGCGTCTT

description:
du145_D06_DMSO__24
DU145_dream_counts.csv


title: du145_E06_UNTREATED__24 DU145PS2BS246_CACCTCTC

description:
du145_E06_UNTREATED__24
DU145_dream_counts.csv


title: du145_C07_Bafetinib_8.5_24 DU145PS2BS223_GTATTCCT

description:
du145_C07_Bafetinib_8.5_24
DU145_dream_counts.csv

value: Bafetinib


title: du145_C06_DMSO__24 DU145PS2BS222_AACCATCC

description:
du145_C06_DMSO__24
DU145_dream_counts.csv

value: DMSO


title: du145_D02_UNTREATED__24 DU145PS2BS230_TGACATGC

description:
du145_D02_UNTREATED__24
DU145_dream_counts.csv


title: du145_C02_UNTREATED__24 DU145PS2BS218_AATTCGTC

description:
du145_C02_UNTREATED__24
DU145_dream_counts.csv


title: du145_B09_Foretinib_0.225_24 DU145PS2BS213_AATGACCG

description:
du145_B09_Foretinib_0.225_24
DU145_dream_counts.csv

value: Foretinib


title: du145_C03_Gefitinib_0.5_24 DU145PS2BS219_AACGTTGT

description:
du145_C03_Gefitinib_0.5_24
DU145_dream_counts.csv

value: Gefitinib

value: ATCC


title: du145_B02_DMSO__24 DU145PS2BS206_GTCCGTTG

description:
du145_B02_DMSO__24
DU145_dream_counts.csv

value: male


title: du145_H11_UNTREATED_0_24 DU145PS2AS191_TGTCGTGA

description:
du145_H11_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_B08_KW2449_0.25_24 DU145PS2BS212_TACTCGAC

description:
du145_B08_KW2449_0.25_24
DU145_dream_counts.csv


title: du145_A09_MK2206_1_24 DU145PS2BS201_CTGGAGGA

description:
du145_A09_MK2206_1_24
DU145_dream_counts.csv


title: du145_H6_AZD5363_0.5_24 DU145PS2AS186_GAATGCTT

description:
du145_H6_AZD5363_0.5_24
DU145_dream_counts.csv


title: du145_A02_DMSO__24 DU145PS2BS194_GAGCTGGT

description:
du145_A02_DMSO__24
DU145_dream_counts.csv


title: du145_G12_Bosutinib_0.375_24 DU145PS2AS180_AAACGACT

description:
du145_G12_Bosutinib_0.375_24
DU145_dream_counts.csv


title: du145_F6_UNTREATED_0_24 DU145PS2AS162_CTCTTACG

description:
du145_F6_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_E9_Neratinib_0.225_24 DU145PS2AS153_TTTCGCTT

description:
du145_E9_Neratinib_0.225_24
DU145_dream_counts.csv


title: du145_G11_UNTREATED_0_24 DU145PS2AS179_TTCAGAGT

description:
du145_G11_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_F8_Tivantinib_0.5_24 DU145PS2AS164_GGCCTGAA

description:
du145_F8_Tivantinib_0.5_24
DU145_dream_counts.csv


title: du145_E11_DMSO_0_24 DU145PS2AS155_TATACGCT

description:
du145_E11_DMSO_0_24
DU145_dream_counts.csv


title: du145_E8_Linifanib_1_24 DU145PS2AS152_TATGTGAC

description:
du145_E8_Linifanib_1_24
DU145_dream_counts.csv


title: du145_E6_UNTREATED_0_24 DU145PS2AS150_CACTCCTG

description:
du145_E6_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_C3_Gefitinib_0.5_24 DU145PS2AS123_TCAGTCTA

description:
du145_C3_Gefitinib_0.5_24
DU145_dream_counts.csv


title: du145_D2_UNTREATED_0_24 DU145PS2AS134_TATGCGTG

description:
du145_D2_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_D6_DMSO_0_24 DU145PS2AS138_AGACAGTG

description:
du145_D6_DMSO_0_24
DU145_dream_counts.csv


title: du145_B9_Foretinib_0.225_24 DU145PS2AS117_GTGAGTGC

description:
du145_B9_Foretinib_0.225_24
DU145_dream_counts.csv


title: du145_G11_UNTREATED_0_24 DU145PS1BS83_GTCGCACA


title: du145_H11_UNTREATED_0_24 DU145PS1BS95_CGGTGATA

description:
du145_H11_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_B8_KW2449_0.25_24 DU145PS2AS116_GAGTACTG

description:
du145_B8_KW2449_0.25_24
DU145_dream_counts.csv


title: du145_F12_Ponatinib_0.135_24 DU145PS1BS72_ATGTAACC

description:
du145_F12_Ponatinib_0.135_24
DU145_dream_counts.csv

value: Ponatinib


title: du145_C2_UNTREATED_0_24 DU145PS2AS122_TGTCAACG

description:
du145_C2_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_B2_DMSO_0_24 DU145PS2AS110_CTGAGGTC

description:
du145_B2_DMSO_0_24
DU145_dream_counts.csv


title: du145_C7_Bafetinib_8.5_24 DU145PS2AS127_ATCAGGCT

description:
du145_C7_Bafetinib_8.5_24
DU145_dream_counts.csv


title: du145_A9_MK2206_1_24 DU145PS2AS105_GTAGAAGT

description:
du145_A9_MK2206_1_24
DU145_dream_counts.csv


title: du145_F11_DMSO_0_24 DU145PS2AS167_GCTAAGAC

description:
du145_F11_DMSO_0_24
DU145_dream_counts.csv


title: du145_A2_DMSO_0_24 DU145PS2AS098_ACATGTTG

description:
du145_A2_DMSO_0_24
DU145_dream_counts.csv


title: du145_C6_DMSO_0_24 DU145PS2AS126_CTGGTCAT

description:
du145_C6_DMSO_0_24
DU145_dream_counts.csv


title: du145_E6_UNTREATED_0_24 DU145PS1BS54_TTTCTCCC


title: du145_G5_Nilotinib_2_24 DU145PS1BS77_GCAAGACG

description:
du145_G5_Nilotinib_2_24
DU145_dream_counts.csv

value: Nilotinib


title: du145_F5_Vandetanib_1.5_24 DU145PS1BS65_TTGCGGAT

description:
du145_F5_Vandetanib_1.5_24
DU145_dream_counts.csv

value: Vandetanib


title: du145_F11_DMSO_0_24 DU145PS1BS71_ATTGTGGC


title: du145_E11_DMSO_0_24 DU145PS1BS59_CTAGCATC

description:
du145_E11_DMSO_0_24
DU145_dream_counts.csv


title: du145_D2_UNTREATED_0_24 DU145PS1BS38_ATCATGTG


title: du145_F6_UNTREATED_0_24 DU145PS1BS66_TCATTGGA

description:
du145_F6_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_C9_Osimertinib_0.36_24 DU145PS1BS33_GGTTTCGC

description:
du145_C9_Osimertinib_0.36_24
DU145_dream_counts.csv

value: Osimertinib


title: du145_C3_Cabozantinib_1_24 DU145PS1BS27_GCTAACGG

description:
du145_C3_Cabozantinib_1_24
DU145_dream_counts.csv

value: Cabozantinib


title: du145_B2_DMSO_0_24 DU145PS1BS14_CAGTACCT


title: du145_C11_Afatinib_0.185_24 DU145PS1BS35_TCCAAGTC

description:
du145_C11_Afatinib_0.185_24
DU145_dream_counts.csv

value: Afatinib


title: du145_A11_Dasatinib_0.02_24 DU145PS1BS11_GCATAGTC

description:
du145_A11_Dasatinib_0.02_24
DU145_dream_counts.csv

value: Dasatinib


title: du145_E1_Regorafenib_5_24 DU145PS1BS49_ACTGACTT

description:
du145_E1_Regorafenib_5_24
DU145_dream_counts.csv

value: Regorafenib


title: du145_A12_Sorafenib_1_24 DU145PS1BS12_TGGCTCTA

description:
du145_A12_Sorafenib_1_24
DU145_dream_counts.csv

value: Sorafenib


title: du145_C2_UNTREATED_0_24 DU145PS1BS26_TTTTACCG

description:
du145_C2_UNTREATED_0_24
DU145_dream_counts.csv

value: UNTREATED


title: du145_A6_Imatinib_5_24 DU145PS1BS06_CGTGCTGA

description:
du145_A6_Imatinib_5_24
DU145_dream_counts.csv

value: Imatinib


title: du145_A2_DMSO_0_24 DU145PS1BS02_CGTTGTCA


title: du145_H11_UNTREATED_0_24 DU145PS1AS575_AGAGTGTC

description:
du145_H11_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_F12_Ponatinib_0.135_24 DU145PS1AS552_ATTGCTCC

description:
du145_F12_Ponatinib_0.135_24
DU145_dream_counts.csv


title: du145_G5_Nilotinib_2_24 DU145PS1AS557_CCGTTCCA


title: du145_G11_UNTREATED_0_24 DU145PS1AS563_ATAGGGCG

description:
du145_G11_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_D11_Sunitinib_0.045_24 DU145PS1BS47_CCGGTGAA

description:
du145_D11_Sunitinib_0.045_24
DU145_dream_counts.csv

value: Sunitinib


title: du145_F11_DMSO_0_24 DU145PS1AS551_TAGGTTTC

description:
du145_F11_DMSO_0_24
DU145_dream_counts.csv

value: DMSO


title: du145_D6_DMSO_0_24 DU145PS1BS42_ACACGCCA

description:
du145_D6_DMSO_0_24
DU145_dream_counts.csv


title: du145_F6_UNTREATED_0_24 DU145PS1AS546_CGAAGAGT


title: du145_A1_Lapatinib_7.5_24 DU145PS1BS01_TGAACACG

description:
du145_A1_Lapatinib_7.5_24
DU145_dream_counts.csv

value: Lapatinib


title: du145_F5_Vandetanib_1.5_24 DU145PS1AS545_CCGCTATC

description:
du145_F5_Vandetanib_1.5_24
DU145_dream_counts.csv


title: du145_E6_UNTREATED_0_24 DU145PS1AS534_ACTATCTG

description:
du145_E6_UNTREATED_0_24
DU145_dream_counts.csv


title: du145_E1_Regorafenib_5_24 DU145PS1AS529_TGAGAAAG


title: du145_C11_Afatinib_0.185_24 DU145PS1AS515_TGAACGTA


title: du145_C6_DMSO_0_24 DU145PS1BS30_AACAGTTG

description:
du145_C6_DMSO_0_24
DU145_dream_counts.csv


title: du145_B5_Crizotinib_0.19_24 DU145PS1BS17_TCTCAGAA

description:
du145_B5_Crizotinib_0.19_24
DU145_dream_counts.csv

value: Crizotinib


title: du145_D6_DMSO_0_24 DU145PS1AS522_GAAGTCCA

value: ATCC


title: du145_C9_Osimertinib_0.36_24 DU145PS1AS513_GAAACATC

description:
du145_C9_Osimertinib_0.36_24
DU145_dream_counts.csv

value: male


title: du145_C2_UNTREATED_0_24 DU145PS1AS506_CCCCTTCA


title: du145_B2_DMSO_0_24 DU145PS1AS494_GACTGAGG

description:
du145_B2_DMSO_0_24
DU145_dream_counts.csv


title: du145_A12_Sorafenib_1_24 DU145PS1AS492_ATGCACTC


title: du145_A2_DMSO_0_24 DU145PS1AS482_CGAAGCCA

description:
du145_A2_DMSO_0_24
DU145_dream_counts.csv


title: du145_A6_Imatinib_5_24 DU145PS1AS486_GGGTTTTA


title: du145_A11_Dasatinib_0.02_24 DU145PS1AS491_TGGACAAC

description:
du145_A11_Dasatinib_0.02_24
DU145_dream_counts.csv


title: du145_A1_Lapatinib_7.5_24 DU145PS1AS481_TCTCCCAC


title: du145_E11_DMSO_0_24 DU145PS1AS539_GACAGTCT

description:
du145_E11_DMSO_0_24
DU145_dream_counts.csv


title: du145_D11_Sunitinib_0.045_24 DU145PS1AS527_TGGTGTGT


title: aspc_F11_DMSO__24 ASPC1PS5BS743_GTGATGAC

description:
aspc_F11_DMSO__24
ASPC_dream_counts.csv

source_name: pancreatic cancer

value: female


title: aspc_G11_UNTREATED__24 ASPC1PS5BS755_GGGCTTCT

description:
aspc_G11_UNTREATED__24
ASPC_dream_counts.csv


title: du145_D2_UNTREATED_0_24 DU145PS1AS518_GACGACTC

description:
du145_D2_UNTREATED_0_24
DU145_dream_counts.csv


title: aspc_H11_UNTREATED__24 ASPC1PS5BS767_ACAAGTCT

description:
aspc_H11_UNTREATED__24
ASPC_dream_counts.csv


title: PminusFeminus76hours1

city: Stanford

first: Yanniv

last: Dorone

address: 371 Jane Stanford Way

institute: Stanford University

data_processing:
Reads were mapped with HISAT2 to the Arabidopsis thaliana TAIR10 reference genome using the Galaxy (Version 2.1.0+galaxy5) web platform.
The resulting BAM files were then analyzed on R using the DESeq2 and TxDB.Athaliana.BioMart.plantsmart28 (Bioconductor) packages. Genes with padj<0.05 were considered differentially expressed.
Genome_build: TAIR10
Supplementary_files_format_and_content: Excel

molecule: polyA RNA

organism: Arabidopsis thaliana

source_name: 7 day old shoots

extract_protocol:
RNeasy Plant Mini Kit (QIAGEN)
KAPA Biosystems RNA HyperPrep Kit

treatment_protocol: Arabidopsis wild-type plants (Col-0 accession) were grown on control (+Fe+P) for 7 days on 0.1X MS then transferred to three different medium: control (+Fe+P), iron deficiency (-Fe+P), and iron and phosphate deficiency conditions (-Fe-P). Shoots were collected 39 h, 52 h and 76 h after the transfer. For RNA-seq experiments, three biological replicates were used for each time point (39h, 52h and 76h) and each condition (+Fe+P, -Fe+P and -Fe-P) for a total of 27 samples.

tag: background ecotype

value: -P-Fe

tag: time

value: 76h after transfer

tag: tissue

value: shoots


title: aspc_F6_UNTREATED__24 ASPC1PS5BS738_GCTTACCA

description:
aspc_F6_UNTREATED__24
ASPC_dream_counts.csv


title: PplusFeminus76hours3

value: +P-Fe


title: aspc_E6_UNTREATED__24 ASPC1PS5BS726_ATTCACAG

description:
aspc_E6_UNTREATED__24
ASPC_dream_counts.csv


title: PplusFeminus76hours2


title: PminusFeminus76hours2


title: PplusFeplus76hours3

value: +P+Fe


title: aspc_E11_DMSO__24 ASPC1PS5BS731_CACCCTAC

description:
aspc_E11_DMSO__24
ASPC_dream_counts.csv


title: du145_C3_Cabozantinib_1_24 DU145PS1AS507_ATTCGTAC

description:
du145_C3_Cabozantinib_1_24
DU145_dream_counts.csv

value: Cabozantinib


title: aspc_D2_UNTREATED__24 ASPC1PS5BS710_GCTGCGTA

description:
aspc_D2_UNTREATED__24
ASPC_dream_counts.csv


title: PplusFeplus76hours2


title: du145_C6_DMSO_0_24 DU145PS1AS510_ACCGCTAG


title: aspc_D6_DMSO__24 ASPC1PS5BS714_CTGTGAGT

description:
aspc_D6_DMSO__24
ASPC_dream_counts.csv


title: PplusFeplus76hours1


title: du145_B5_Crizotinib_0.19_24 DU145PS1AS497_AGGTTGGA


title: aspc_C6_DMSO__24 ASPC1PS5BS702_TCCAGCAA

description:
aspc_C6_DMSO__24
ASPC_dream_counts.csv


title: PminusFeminus52hours3

value: 52h after transfer


title: PminusFeminus76hours3


title: aspc_C2_UNTREATED__24 ASPC1PS5BS698_AGCAGCGT

description:
aspc_C2_UNTREATED__24
ASPC_dream_counts.csv


title: aspc_B2_DMSO__24 ASPC1PS5BS686_CTAATCCC

description:
aspc_B2_DMSO__24
ASPC_dream_counts.csv


title: aspc_A2_DMSO__24 ASPC1PS5BS674_GGAGGGAA

description:
aspc_A2_DMSO__24
ASPC_dream_counts.csv


title: PminusFeminus52hours1


title: aspc_H11_UNTREATED__24 ASPC1PS5AS671_TAACCCGA


title: PplusFeminus52hours3


title: aspc_G11_UNTREATED__24 ASPC1PS5AS659_ATACGCAT


title: PplusFeminus52hours2


title: aspc_F11_DMSO__24 ASPC1PS5AS647_CTGCCAAC

description:
aspc_F11_DMSO__24
ASPC_dream_counts.csv


title: PplusFeminus52hours1


title: aspc_E11_DMSO__24 ASPC1PS5AS635_GAGAGAAA

description:
aspc_E11_DMSO__24
ASPC_dream_counts.csv


title: aspc_F6_UNTREATED__24 ASPC1PS5AS642_AGATAGGT


title: PplusFeplus52hours2


title: aspc_D6_DMSO__24 ASPC1PS5AS618_GTTGTTGT

description:
aspc_D6_DMSO__24
ASPC_dream_counts.csv


title: aspc_D2_UNTREATED__24 ASPC1PS5AS614_GGCGTTCA


title: aspc_C2_UNTREATED__24 ASPC1PS5AS602_GAGGTCTT


title: PplusFeplus52hours1


title: PminusFeminus39hours1

value: 39h after transfer


title: aspc_E6_UNTREATED__24 ASPC1PS5AS630_AACTTGGC

value: UNTREATED


title: PminusFeminus39hours3


title: PminusFeminus39hours2


title: PminusFeminus52hours2


title: aspc_B2_DMSO__24 ASPC1PS5AS590_CGTGTAGG

description:
aspc_B2_DMSO__24
ASPC_dream_counts.csv


title: aspc_C6_DMSO__24 ASPC1PS5AS606_TATGGCCA

description:
aspc_C6_DMSO__24
ASPC_dream_counts.csv


title: PplusFeminus39hours3


title: PplusFeminus39hours2


title: PplusFeminus39hours1


title: PplusFeplus39hours3


title: aspc_A2_DMSO__24 ASPC1PS5AS578_AGACGTTT

description:
aspc_A2_DMSO__24
ASPC_dream_counts.csv


title: PplusFeplus39hours1


title: PplusFeplus39hours2


title: aspc_G11_UNTREATED_0_24 ASPCPS4BS83_GTCGCACA

description:
aspc_G11_UNTREATED_0_24
ASPC_dream_counts.csv


title: PplusFeplus52hours3


title: aspc_E11_DMSO_0_24 ASPCPS4BS59_CTAGCATC

description:
aspc_E11_DMSO_0_24
ASPC_dream_counts.csv


title: aspc_F11_DMSO_0_24 ASPCPS4BS71_ATTGTGGC

description:
aspc_F11_DMSO_0_24
ASPC_dream_counts.csv


title: aspc_E6_UNTREATED_0_24 ASPCPS4BS54_TTTCTCCC

description:
aspc_E6_UNTREATED_0_24
ASPC_dream_counts.csv


title: 20% distal portion of BA4 at HH15

city: Kansas City

first: Madelaine

last: Gogol

state: MO

address: 1000 E. 50th Street

department: Computational Biology Core

institute: Stowers Institute

description:
10X Genomics Chromium scRNA-seq
HH15_BA4_Front

data_processing:
Data was processed with bcl2fastq (2.20) and aligned and aggregated with CellRanger (2.1.0).
Data was aligned to galGal4 using annotations from Ensembl 84.
Downstream analysis was done in R (3.5.0) with the Seurat package (2.3.4).
Cells were kept for downstream analysis if they had more than 500 genes expressed, less than 20,000 UMIs, and less than 30% mitochondrial expression.
2796 genes were selected as variable genes for downstream analysis, and the first 50 principal components were used for later steps (UMAP and cluster identification).
For identifying cluster markers, we used FindAllMarkers with the minimum percentage of cells within a cluster expressing the gene set to 25% and a log fold change threshold of greater than or equal to 0.25.
To further investigate some clusters, we performed subclustering by subsetting the Seurat object by cluster and running FindClusters at higher resolutions.
Genome_build: Data was aligned to galGal4 using annotations from Ensembl 84.
Supplementary_files_format_and_content: One tab-delimited text file generated from the Seurat data slot (default, Log-normalized data). Rows are genes labeled by ensembl ids, columns are cell barcodes with hyphen appended numbers for each combined sample (in same order as samples: hh13_ba1_back = 1, hh13_ba1_front = 2, hh13_ba2_back = 3, hh13_ba2_front = 4, hh15_ba3_back = 5, hh15_ba3_front = 6, hh15_ba4_back = 7, hh15_ba4_front = 8

organism: Gallus gallus

growth_protocol: Fertilized, white leghorn chicken eggs (NCBI Taxonomy ID:9031; Centurion Poultry, Lexington, GA, USA) were incubated at 38 degrees C in a humidified incubator until the desired Hamburger and Hamilton (HH) stage (Hamburger and Hamilton 1951) of development.

extract_protocol:
All experiments were performed according to institutional and federal ethical standards. Fertilized, white leghorn chicken eggs (NCBI Taxonomy ID:9031; Centurion Poultry Inc., Lexington, GA, USA) were incubated at 38 degrees C in a humidified incubator until the desired Hamburger and Hamilton (HH) stage (Hamburger and Hamilton 1951) of development.  Embryos were screened for health and harvested into chilled 0.1% DEPC phosphate-buffered saline (PBS). To capture neural crest during active migration, branchial arches (BA) 1 and 2 were manually isolated from HH 13 embryos (n=15 embryos). Branchial arches 3 and 4 were manually isolated from HH 15 embryos (n=10 embryos). Each branchial arch was further manually dissected into the front 20% (distal-most) and 80% back (proximal-most) portions. Stage-, branchial arch- and tissue portion-matched tissues were pooled and dissociated as previously described (Morrison 2015). The viability and concentration of each single cell suspension was quickly confirmed on a Nexelome Cellometer Auto T4 (Nexelome Bioscience, Lawrence, MAassachusetts, USA) and the cell suspensions used as input for 10X scRNA-seq (10X Genomics, San Francisco, CA, USA) per the manufacturer’s recommendations.
Dissociated cells were loaded on a Chromium Single Cell Controller (10x Genomics, Pleasanton, CA, USA), based on live cell concentration, with a target of 4,000-10,000 cells per sample. Libraries were prepared using the Chromium Single Cell 3' Library & Gel Bead Kit v2 (10x Genomics, Pleasanton, CA, USA) according to manufacturer’s directions. Resulting short fragment libraries were checked for quality and quantity using an Bioanalyzer 2100 (Agilent Technologies, Santa, Calara, CA, USA) and Qubit Fluorometer (Invitrogen, Waltham, MA, USA).
Libraries were pooled and sequenced to a depth necessary to achieve 25-35,000 mean reads per cell, 125-520M reads each, on an Illumina HiSeq 2500 (Illumina, San Diego, CA, USA) instrument using Rapid SBS v2 chemistry with the following paired read lengths: 26 bp Read1, 8 bp I7 Index and 98 bp Read2.

treatment_protocol: wild type; unlabeled & unperturbed

tag: hamburger and hamilton (hh) stage

value: HH stage 15

tag: branchial arch (ba)

tag: portion of branchial arch

value: 20percent distal portion

tag: genotype

value: wild type


title: 20% distal portion of BA3 at HH15

description:
10X Genomics Chromium scRNA-seq
HH15_BA3_Front


title: aspc_H11_UNTREATED_0_24 ASPCPS4BS95_CGGTGATA

description:
aspc_H11_UNTREATED_0_24
ASPC_dream_counts.csv


title: 80% proximal portion of BA2 at HH13

description:
10X Genomics Chromium scRNA-seq
HH13_BA2_Back

value: HH stage 13

value: 80percent proximal portion


title: aspc_D6_DMSO_0_24 ASPCPS4BS42_ACACGCCA

description:
aspc_D6_DMSO_0_24
ASPC_dream_counts.csv

value: DMSO

value: ATCC


title: 80% proximal portion of BA4 at HH15

description:
10X Genomics Chromium scRNA-seq
HH15_BA4_Back


title: 20% distal portion of BA1 at HH13

description:
10X Genomics Chromium scRNA-seq
HH13_BA1_Front


title: aspc_B2_DMSO_0_24 ASPCPS4BS14_CAGTACCT

description:
aspc_B2_DMSO_0_24
ASPC_dream_counts.csv

value: female


title: aspc_A2_DMSO_0_24 ASPCPS4BS02_CGTTGTCA

description:
aspc_A2_DMSO_0_24
ASPC_dream_counts.csv


title: aspc_C2_UNTREATED_0_24 ASPCPS4BS26_TTTTACCG

description:
aspc_C2_UNTREATED_0_24
ASPC_dream_counts.csv


title: aspc_C6_DMSO_0_24 ASPCPS4BS30_AACAGTTG

description:
aspc_C6_DMSO_0_24
ASPC_dream_counts.csv


title: aspc_D2_UNTREATED_0_24 ASPCPS4BS38_ATCATGTG

description:
aspc_D2_UNTREATED_0_24
ASPC_dream_counts.csv


title: aspc_H11_UNTREATED_0_24 ASPC1PS4AH11_CGGTGATA


title: miRNA expression of ESCC tissue [C199T_NS]

type: RNA

city: Shantou

first: Yang

last: Chen

address: Department of Biochemistry and Molecular Biology, Shantou University Medical College, 22 Xinling Road, Shantou

country: China

institute: Shantou University Medical College

description: After the homogenization of the sample hybridization signal, the signal value after logarithmic transformation was performed on the base of 2.

hyb_protocol: Each slide was hybridized with 100ng Cy3-labeled RNA using miRNA Complete Labeling and Hyb Kit(Cat#5190-0456, Agilent technologies, Santa Clara, CA, US)in hybridization Oven(Cat#G2545A, Agilent technologies, Santa Clara, CA, US)at 55℃，20rpm for 20 hours according to the manufacturer’s instructions, hybridization section. After hybridization, slides were washed in staining dishes (Cat#121, Thermo Shandon, Waltham, MA, US) with Gene Expression Wash Buffer Kit(Cat#5188-5327, Agilent technologies, Santa Clara, CA, US).

scan_protocol: Slides were scanned by Agilent Microarray Scanner(Cat#G2565BA，Agilent technologies, Santa Clara, CA, US)

data_processing:
Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US)with default settings.
Raw data were normalized by Quantile algorithm, Gene Spring Software 11.0(Agilent technologies, Santa Clara, CA, US).

source_name: ESCC tissue

label_protocol: miRNA molecular in total RNA was labeled by miRNA Complete Labeling and Hyb Kit(Cat#5190-0456, Agilent technologies, Santa Clara, CA, US)followed the manufacturer’s instructions, labeling section.

tag: gender

value: Male

value: esophagus


title: miRNA expression of ESCC tissue [C200T_NS]

extract_protocol: miRNA molecular in total RNA was labeled by miRNA Complete Labeling and Hyb Kit(Cat#5190-0456, Agilent technologies, Santa Clara, CA, US)followed the manufacturer’s instructions, labeling section.

value: Female


title: 80% proximal portion of BA3 at HH15

description:
10X Genomics Chromium scRNA-seq
HH15_BA3_Back


title: aspc_F6_UNTREATED_0_24 ASPCPS4BS66_TCATTGGA

description:
aspc_F6_UNTREATED_0_24
ASPC_dream_counts.csv


title: miRNA expression of mathched normal esophagus tissue [C200N_NS]

source_name: normal esophagus tissue


title: 20% distal portion of BA2 at HH13

description:
10X Genomics Chromium scRNA-seq
HH13_BA2_Front


title: aspc_G11_UNTREATED_0_24 ASPC1PS4AG11_GTCGCACA


title: miRNA expression of mathched normal esophagus tissue [C199N_NS]


title: miRNA expression of ESCC tissue [B804T_NS]


title: aspc_E11_DMSO_0_24 ASPC1PS4AE11_CTAGCATC


title: miRNA expression of ESCC tissue [B801T_NS]


title: aspc_F6_UNTREATED_0_24 ASPC1PS4AF06_TCATTGGA


title: aspc_F11_DMSO_0_24 ASPC1PS4AF11_ATTGTGGC


title: 80% proximal portion of BA1 at HH13

description:
10X Genomics Chromium scRNA-seq
HH13_BA1_Back


title: aspc_E6_UNTREATED_0_24 ASPC1PS4AE06_TTTCTCCC


title: miRNA expression of mathched normal esophagus tissue [B801N_NS]


title: miRNA expression of ESCC tissue [B800T_NS]


title: miRNA expression of mathched normal esophagus tissue [B800N_NS]


title: aspc_D6_DMSO_0_24 ASPC1PS4AD06_ACACGCCA

description:
aspc_D6_DMSO_0_24
ASPC_dream_counts.csv


title: miRNA expression of ESCC tissue [B799T_NS]


title: aspc_D2_UNTREATED_0_24 ASPC1PS4AD02_ATCATGTG


title: aspc_C6_DMSO_0_24 ASPC1PS4AC06_AACAGTTG

description:
aspc_C6_DMSO_0_24
ASPC_dream_counts.csv


title: miRNA expression of ESCC tissue [B798T_NS]


title: aspc_B2_DMSO_0_24 ASPC1PS4AB02_CAGTACCT

description:
aspc_B2_DMSO_0_24
ASPC_dream_counts.csv


title: miRNA expression of mathched normal esophagus tissue [B798N_NS]


title: miRNA expression of mathched normal esophagus tissue [B804N_NS]


title: miRNA expression of ESCC tissue [B797T_NS]


title: aspc_H11_UNTREATED_0_24 ASPCPS3BH11_CGGTGATA


title: aspc_C2_UNTREATED_0_24 ASPC1PS4AC02_TTTTACCG


title: aspc_A2_DMSO_0_24 ASPC1PS4AA02_CGTTGTCA

description:
aspc_A2_DMSO_0_24
ASPC_dream_counts.csv


title: miRNA expression of mathched normal esophagus tissue [B799N_NS]


title: miRNA expression of mathched normal esophagus tissue [B797N_NS]


title: aspc_E11_DMSO_0_24 ASPCPS3BE11_CTAGCATC


title: miRNA expression of ESCC tissue [B791T_NS]


title: aspc_F11_DMSO_0_24 ASPCPS3BF11_ATTGTGGC


title: miRNA expression of mathched normal esophagus tissue [B791N_NS]


title: aspc_G10_Neratinib_0.225_24 ASPCPS3BG10_CCAGGCAA

description:
aspc_G10_Neratinib_0.225_24
ASPC_dream_counts.csv

value: Neratinib


title: aspc_G11_UNTREATED_0_24 ASPCPS3BG11_GTCGCACA

description:
aspc_G11_UNTREATED_0_24
ASPC_dream_counts.csv


title: miRNA expression of mathched normal esophagus tissue [B794N_NS]


title: miRNA expression of ESCC tissue [B794T_NS]


title: aspc_F10_Foretinib_0.255_24 ASPCPS3BF10_AGATGCTA

description:
aspc_F10_Foretinib_0.255_24
ASPC_dream_counts.csv

value: Foretinib


title: aspc_F9_Tivantinib_0.345_24 ASPCPS3BF09_CAGTTCGG

description:
aspc_F9_Tivantinib_0.345_24
ASPC_dream_counts.csv

value: Tivantinib


title: aspc_D9_MK2206_0.5_24 ASPCPS3BD09_CGCAAAAT

description:
aspc_D9_MK2206_0.5_24
ASPC_dream_counts.csv


title: miRNA expression of ESCC tissue [B783T_NS]


title: miRNA expression of mathched normal esophagus tissue [B786N_NS]


title: aspc_D6_DMSO_0_24 ASPCPS3BD06_ACACGCCA

description:
aspc_D6_DMSO_0_24
ASPC_dream_counts.csv


title: miRNA expression of ESCC tissue [B786T_NS]


title: aspc_F6_UNTREATED_0_24 ASPCPS3BF06_TCATTGGA


title: miRNA expression of mathched normal esophagus tissue [B788N_NS]


title: aspc_C6_DMSO_0_24 ASPCPS3BC06_AACAGTTG

description:
aspc_C6_DMSO_0_24
ASPC_dream_counts.csv


title: aspc_B4_Varlitinib_0.5_24 ASPCPS3BB04_ATGCCTCA

description:
aspc_B4_Varlitinib_0.5_24
ASPC_dream_counts.csv

value: Varlitinib


title: miRNA expression of ESCC tissue [B785T_NS]


title: aspc_E6_UNTREATED_0_24 ASPCPS3BE06_TTTCTCCC

description:
aspc_E6_UNTREATED_0_24
ASPC_dream_counts.csv


title: aspc_D2_UNTREATED_0_24 ASPCPS3BD02_ATCATGTG


title: miRNA expression of mathched normal esophagus tissue [B785N_NS]


title: aspc_H8_KW2449_7_24 ASPCPS3BH08_TCGTTAAG

description:
aspc_H8_KW2449_7_24
ASPC_dream_counts.csv


title: aspc_C9_Linifanib_1_24 ASPCPS3BC09_GGTTTCGC

description:
aspc_C9_Linifanib_1_24
ASPC_dream_counts.csv

value: Linifanib


title: miRNA expression of ESCC tissue [B788T_NS]


title: aspc_H11_UNTREATED_0_24 ASPCPS3AH11_CGGTGATA

description:
aspc_H11_UNTREATED_0_24
ASPC_dream_counts.csv

value: UNTREATED


title: GSR13_KPM3

city: Munich

first: Georgios

middle: T

last: Stathopoulos

state: Bayern

address: Max-Lebsche-Platz

department: Comprehensive Pneumology Center

country: Germany

institute: Helmholz Zentrum Munich

data_processing:
The raw bam files, one for each RNA-Seq sample, were summarized to a gene read counts table, using the Bioconductor package GenomicRanges. In the final read counts table, each row represented one gene, each column one RNA-Seq sample and each cell, the corresponding read counts associated with each row and column.The gene counts table was normalized for inherent systematic or experimental biases (e.g. sequencing depth, gene length, GC content bias etc.) using the Bioconductor package DESeq after removing genes that had zero counts over all the RNA-Seq samples (20007 genes). The output of the normalization algorithm was a table with normalized counts, which can be used for differential expression analysis with statistical algorithms developed specifically for count data. Prior to the statistical testing procedure, the gene read counts were filtered for possible artifacts that could affect the subsequent statistical testing procedures. Genes presenting any of the following were excluded from further analysis: i) genes with length less than 500 (2051 genes), ii) genes whose average reads per 100 bp was less than the 25th quantile of the total normalized distribution of average reads per 100bp (0 genes with cutoff value 0.02248 average reads per 100 bp), iii) genes with read counts below the median read counts of the total normalized count distribution (11358 genes with cutoff value 16 normalized read counts). The total number of genes excluded due to the application of gene filters was 5298. The total (unified) number of genes excluded due to the application of all filters was 32595. The resulting gene counts table was subjected to differential expression analysis for the contrasts WT versus KPM using the Bioconductor package DESeq. The final numbers of differentially expressed genes were (per contrast): for the contrast WT versus KPM, 2344 (735) statistically significant genes were found with a p-value (FDR or adjusted p-value) threshold of 0.05 and of these, 650 (132) were up-regulated, 1694 (603) were down-regulated and 0 (0) were not differentially expressed according to an absolute fold change cutoff value of 1 in log2 scale. Literature references for all the algorithms used can be found at the end of this report.
Genome_build: mm10
Supplementary_files_format_and_content: excel datasheet contatining the fold change between the two groups, naïve wt mesothelial cells vs KP cells (mouse malignant pleural mesothelioma)

organism: Mus musculus

source_name: KPM 3 cell line

growth_protocol: KPM cells were cultured in minimum supplemented medium (DMEM+10% FBS + 1% PEN/STREP) for over 6 months, for over 30 passages. Mouse wilt type mesothelial cells were not cultured. We proceeded to total RNA extraction after cell isolation from the pleural space.

extract_protocol:
Total RNA from the cells was extracted with the Trizol protocol followed by Qiagen RNeasy Mini Kit.
Libraries were prepared according to Thermoscientific Ion Torrent specifications.

tag: cell type

value: Mouse malignant mesothelioma cells

tag: passages

value: Over 30

tag: strain


title: miRNA expression of ESCC tissue [B782T_NS]


title: GSR11_wt1

source_name: WT Mesothelial Cells

value: Mouse naive mesothelial cells


title: aspc_C2_UNTREATED_0_24 ASPCPS3BC02_TTTTACCG

description:
aspc_C2_UNTREATED_0_24
ASPC_dream_counts.csv

tag: treatment


title: aspc_B2_DMSO_0_24 ASPCPS3BB02_CAGTACCT

description:
aspc_B2_DMSO_0_24
ASPC_dream_counts.csv

tag: cell line


title: aspc_A2_DMSO_0_24 ASPCPS3BA02_CGTTGTCA

description:
aspc_A2_DMSO_0_24
ASPC_dream_counts.csv

tag: provider


title: miRNA expression of mathched normal esophagus tissue [B783N_NS]


title: aspc_E3_Regorafenib_5_24 ASPCPS3BE03_TTACCGTG

description:
aspc_E3_Regorafenib_5_24
ASPC_dream_counts.csv

value: Regorafenib

tag: vendor id


title: miRNA expression of mathched normal esophagus tissue [B782N_NS]

description: After the homogenization of the sample hybridization signal, the signal value after logarithmic transformation was performed on the base of 2.


title: GSR12_KPM1

source_name: KPM 1 cell line


title: GSR14_KPM4

source_name: KPM 4 cell line


title: GT1-13-100ng

city: Rochester

first: Jin Sung

last: Jang

address: 200 1st st sw

institute: Mayo Clinic

description: GT1-13-100ng.FC000000000-JCB58_L1_R1_ITGCCATGTTCGG-TGAACTGTTAGG

data_processing:
The STAR (2.6.1d) aligner was used to perform alignment of reads to the hg38. After alignment, the final BAM files were quantified using Partek E/M algorithm by Ensembl annotations (Ensembl Transcripts release 92) after deduplicating UMI.
Genome_build: hg38, Ensembl Transcripts release 92
Supplementary_files_format_and_content: tab-delimited text files and gene counts

source_name: FFPE

extract_protocol:
Qiagen miRNeasy FFPE kit and Trizol
1ng to 100ng of total RNA from each sample was used. The RNA-Seq libraries were generated using QuantSeq 3’ mRNA-Seq Library Prep Kit-FWD (Lexogen, Vienna, Austria).

tag: input amounts

tag: protocol

value: Low Input


title: EF1-20-100ng

description: EF1-20-100ng.FC000000000-JCB58_L1_R1_ICTTAATGATATC-ATTCCTGCTCTA


title: JB1-19%

description: JB1-19.FC000000000-J77VF_L1_R1_ICTGTAGTCGCCA-ATGTCGTAGAAC


title: GT1-30-100ng

description: GT1-30-100ng.FC000000000-JCB58_L1_R1_ICGGGTAGGGCGT-AGGGTCGGGAGT


title: GT1-30%

description: GT1-30.FC000000000-J77VF_L1_R1_ITCGAGTCCCGGA-TAGCGTAAAGGC


title: GT1-13%

description: GT1-13.FC000000000-J77VF_L1_R1_ITCCTAGCGATTT-TAATCGAGCTTT


title: aspc_G11_UNTREATED_0_24 ASPCPS3AG11_GTCGCACA

description:
aspc_G11_UNTREATED_0_24
ASPC_dream_counts.csv

tag: age

tag: Sex


title: aspc_G10_Neratinib_0.225_24 ASPCPS3AG10_CCAGGCAA

description:
aspc_G10_Neratinib_0.225_24
ASPC_dream_counts.csv


title: aspc_F9_Tivantinib_0.345_24 ASPCPS3AF09_CAGTTCGG

description:
aspc_F9_Tivantinib_0.345_24
ASPC_dream_counts.csv


title: aspc_F11_DMSO_0_24 ASPCPS3AF11_ATTGTGGC

description:
aspc_F11_DMSO_0_24
ASPC_dream_counts.csv

value: DMSO


title: aspc_F10_Foretinib_0.255_24 ASPCPS3AF10_AGATGCTA

description:
aspc_F10_Foretinib_0.255_24
ASPC_dream_counts.csv

value: ATCC


title: aspc_E11_DMSO_0_24 ASPCPS3AE11_CTAGCATC

description:
aspc_E11_DMSO_0_24
ASPC_dream_counts.csv

value: female


title: aspc_C9_Linifanib_1_24 ASPCPS3AC09_GGTTTCGC

description:
aspc_C9_Linifanib_1_24
ASPC_dream_counts.csv


title: aspc_F6_UNTREATED_0_24 ASPCPS3AF06_TCATTGGA

description:
aspc_F6_UNTREATED_0_24
ASPC_dream_counts.csv


title: aspc_D9_MK2206_0.5_24 ASPCPS3AD09_CGCAAAAT

description:
aspc_D9_MK2206_0.5_24
ASPC_dream_counts.csv


title: aspc_H8_KW2449_7_24 ASPCPS3AH08_TCGTTAAG

description:
aspc_H8_KW2449_7_24
ASPC_dream_counts.csv


title: BF2-38%

description: BF2-38.FC000000000-J77VF_L1_R1_ICCGTTGAAGGGG-AAGTTGCCGGGG


title: EF1-30%

description: EF1-30.FC000000000-J77VF_L1_R1_ICAAGGTCCCCTT-ACCGGTAAAATT


title: EF1-20%

description: EF1-20.FC000000000-J77VF_L1_R1_ICCGCCCTATTTC-AAGAAATCTTTA


title: aspc_E6_UNTREATED_0_24 ASPCPS3AE06_TTTCTCCC

description:
aspc_E6_UNTREATED_0_24
ASPC_dream_counts.csv